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Abstract  45 
Chicken anaemia virus (CAV) is a lymphotropic virus that causes anaemia and 46 
immunosuppression in chickens. Previously, we proposed that CAV evades host antiviral 47 
responses in vivo by disrupting T-cell signaling, but the precise cellular targets and modes 48 
of action remain elusive. In this study, we examined gene expression in Marek’s disease 49 
virus transformed chicken T-cell line (MSB-1) after infection with CAV using both a 50 
custom 5K immune focused microarray and quantitative Real-time PCR at 24, 48 and 72 51 
h post infection. The data demonstrate an intricate equilibrium between CAV and the host 52 
gene expression, displaying subtle but significant modulation of transcripts involved in 53 
the T-cell-, inflammation- and NF-B-signaling cascades. CAV efficiently blocked the 54 
induction of type-I interferons and interferon stimulated genes at 72 h. The cell 55 
expression pattern implies that CAV subverts host antiviral responses and that the 56 
transformed environment of MSB-1 cells offers an opportunistic advantage for virus 57 
growth. 58 
 59 
Text  60 
Chicken anaemia virus (CAV) is a small, non-enveloped, DNA virus that contains a single-61 
stranded circular genome of 2.3 kb and causes significant economic losses in the 62 
production of young birds worldwide. In older birds CAV causes a subclinical disease that 63 
compromises vaccination and aggravates secondary coexisting infections especially with 64 
Marek’s disease virus [1, 2]. The CAV genome encodes 3 partially overlapping open 65 
reading frames that are translated to produce the structural VP1 protein (52 kDa), the 66 
putative immunomodulatory VP2 protein (24 kDa) and VP3 (13 kDa), which induces 67 
apoptosis in infected cells. VP3 or apoptin also induces tumor selective apoptosis in a 68 
range of human cancer cells and is a potential anti-cancer therapeutic agent [3].  69 
CAV targets erythroid and lymphoid progenitor cells in the bone marrow and thymus, 70 
respectively, while B-cells appear unaffected by the virus [4, 5]. The mechanisms that the 71 
virus employs to trigger apoptosis, to evade host anti-viral processes and to exploit the 72 
host cellular resources have not been elucidated. We previously reported that in two-73 
week old chickens at 14 days post infection (p.i.) with CAV, pro-apoptotic genes such as 74 
the Bcl-2 family member Bcl2-antagonist/killer 1 (BAK1) are upregulated in thymus cells, 75 
consistent with the extensive apoptosis of thymus cells that is observed macroscopically 76 
following viral infection [6]. We also observed a significant virus-induced modulation of 77 
the expression of genes involved in TCR-signaling. A virus-induced dysregulation of TCR- 78 
signalling may provide a strategic mechanism for virus escape from the host immune 79 
system. However, given the complexity of genetic and epigenetic alterations in in vivo 80 
conditions, which can mask important cell signaling events, an in vitro system may be 81 
more appropriate to systematically dissect the mechanisms involved in viral 82 
pathogenesis. CAV can grow in chick embryos and a limited number of transformed B- 83 
and T-lymphoblastoid cell lines [7-10]. The most commonly used cell line is the 84 
immortalised Marek’s disease virus (MDV)-transformed chicken lymphoblastoid cell line 85 
MDCC-MSB-1 (MSB-1), which consists of MDV-virus transformed chicken lymphocytes 86 
[including mature helper T-lymphocytes (CD3+, CD4+, CD8-, TCR2+)] derived from a MDV 87 
T- cell splenic lymphoma. MDV is another economically important poultry disease and is 88 
caused by an avian α-herpesvirus that frequently coexists with CAV in infected chicken 89 
flocks [11, 12]. Crowley et al used a 20K-oligo microarray chip (ARK Genomics, Roslin 90 
Institute, now Edinburgh Genomics) and showed that CAV infection of MSB-1 cells for 24 91 
and 48 h, induced transcripts involved in inflammation, apoptosis, and antiviral activity 92 
[13]. Due to the rudimentary annotation of early chicken genome assemblies (2.1 genome 93 
assembly), this earlier study identified many transcripts which lacked annotation [13]. 94 
Our study aimed to confirm and extend this study by assessing CAV-induced host gene 95 
expression using a more extended timeframe of infection, a lower multiplicity of infection 96 
(MOI), and an in-house immune-focused microarray chip. This chip was developed by 97 
Edinburgh Genomics (Roslin Institute) and had a better coverage of immune-related 98 
genes than the other existing chicken microarray chips [14]. The data of the study was re-99 
annotated with the latest chicken genome assembly (Gallus_gallus-5.0; 100 
GCA_000002315.3). Employing an immune-focused array can circumvent problems 101 
typically associated with universal arrays, such as the extensive amounts of biological 102 
information produced or elimination of relevant data through multiple-testing correction 103 
to significance levels. 104 
 105 
MSB-1 cells grow in suspension culture and require subculturing at intervals of around 3 106 
days and are resistant to infection by most other avian viruses except retroviruses [15, 107 
16]. The level of cell-associated infectivity reaches a maximum between 36 and 48 h after 108 
infection and coincides with the period when maximal levels of viral antigen can be 109 
detected by immunofluorescence [17]. We have found that cell-free infectivity peaks 110 
between 72 and 84 h p.i. (data not shown), in agreement with previous studies [17]. We 111 
conducted a time-course investigation (at 24, 48 and 72 h p.i.) of the host gene expression 112 
profile in CAV-infected MSB-1 cells using both a 5K immune-focused microarray cDNA 113 
array [14] and quantitative RT-PCR (qRT-PCR). MSB-1 cells were grown and infected with 114 
the Cux-1 CAV strain at an MOI of 1 as previously described [15]. Six replicate samples 115 
from Cux-1-infected and mock-infected MSB-1 cells were collected at each time point and 116 
total RNA was extracted. Total RNA was isolated, evaluated and divided for microarray 117 
analyses and qRT-PCR, using previously described procedures and qRT-PCR primers [6]. 118 
Samples were processed and hybridised on the immune-focused cDNA microarray 119 
representing 5,026 chicken genes (the study’s data have been deposited in ArrayExpress; 120 
Accession: E-MEXP-1229). Genes with a false discovery rate (FDR) of more than 5% in 121 
either set of data were excluded from further analyses. The cut-off fold gene expression 122 
change was set at ≥ ±1.5. Ingenuity Pathway Analysis software (Ingenuity Systems, 123 
Redwood City, CA) was used to associate differentially expressed genes with biological 124 
pathways and functional gene networks, matrix2png v1.2.1 for data clustering, and R 125 
v3.3.3 for multidimensional scaling (MDS) of microarray samples. Analyses of the 126 
differences between transcripts from mock and infected cells found with qRT-PCR were 127 
carried out using one-way ANOVA and a Bonferroni multiple comparisons test with 128 
p<0.05 considered significant. For both microarrays and qRT-PCR assays a reference 129 
design was used where each experimental sample was compared against a common 130 
reference sample, which was obtained by pooling all samples at each time point. This 131 
enabled samples to be directly compared with each other. 132 
Prior to differential gene expression analysis, the data from the microarray probes were 133 
used for MDS, which displays sample variability in two-dimensional space (Fig. 1A). MDS 134 
analysis demonstrated that samples were differentiated by time point along coordinate 1, 135 
while coordinate 2 separated samples by treatment status (i.e. infected versus mock 136 
samples). Samples from infected (24 h) and mock-infected cells (24 and 48 h), and 137 
infected cells at 48 and 72 h were clustered together in two groups, while the mock-138 
infected cells at 72 h were distinct from the rest of the samples, possibly due to the 139 
extended culture duration. Using a stringent set of criteria, we found a total of 385 140 
transcripts with FDR 0.05 that were differentially expressed (DE) in CAV-infected cells 141 
compared with mock-infected cells at all time points (Fig. 1B and Supplementary data). 142 
The most noticeable changes in host gene expression occurred between 48 and 72 h p.i. 143 
(Fig. 1B). More transcripts (156) were downregulated than were upregulated (119) at 72 144 
h p.i. and only 18 transcripts overlapped between 48 and 72 h (Fig. 1C and Supplementary 145 
data). Overall there were different expression trends at different time points, implying 146 
distinct cascades of host gene response. 147 
DE transcripts were updated in annotation terms and gene IDs using probe sequence 148 
information and BLAST analysis. The list of updated gene IDs and the expression data 149 
were then processed into Ingenuity pathway software and analysed for known 150 
“canonical” pathways and biological functions (full analysis is presented in 151 
Supplementary data). Analysis identified diverse biological process categories at 48 h, 152 
with the more abundant categories including cell-to-cell signaling and interaction, tissue 153 
development and morphology, immune response and molecular transport, possibly 154 
relating to the virus need for the host machinery to replicate itself. The most enriched 155 
pathways were involved in T-cell signaling. At 72 h the most abundant biological function 156 
categories were cell death, cell growth and proliferation, and immunological disease, 157 
while the most affected pathways were purine and pyrimidine metabolism, integrin- and 158 
glucocorticoid- receptor signaling, and T-cell signaling. 159 
In the heatmap rendering of T-cell receptor signaling, inflammation and cytokine 160 
signaling pathways in mock- and CAV-infected cells (Fig. 2A) a complex gene expression 161 
pattern is shown, suggestive of deregulated T-cell, proinflammatory and innate immune 162 
responses.  Activation of mammalian T-cells involves a complex cascade of multiple signal 163 
transduction pathways that is initiated at the membrane T-cell receptors (TCR) and 164 
results in the transcription of multiple genes within the nucleus. Infection studies in 165 
chicken T-cells are compromised by a lack of understanding of the chicken T-cell 166 
activation/signaling circuits and further impaired by the partial understanding of the 167 
overall chicken immune system, including the type I IFN response, which is the first line 168 
of host defence upon virus infection. Downregulation of genes involved in TCR signalling, 169 
such as those for TCRα, TCRδ, CD3δ, and upregulation of the genes for CD80, CD83 and 170 
the negative TCR signaling regulator, SLA (Fig. 2A), corroborate the CAV–induced T-cell 171 
dysfunction that we described in vivo [6] and were not reported by Crowley et al [13].  172 
At 24 h p.i. a fatty acid desaturase (FADS6) was upregulated and protein kinase delta 1 173 
(PRKCD) was downregulated. PRKCD plays a critical role in the control of growth, 174 
differentiation, and apoptosis [18]. At 48 and particularly 72 h p.i., the pro-inflammatory 175 
cytokine MIF, the MAPK signaling components MAP3K3 and CXXC5, the pro-inflammatory 176 
ligand receptor, IFNγ-R2, STAT3 and NF-κB1 were upregulated, showing late activation 177 
of the type II IFN response, the inflammation response and NF-κB signaling cascades (Fig. 178 
2A and 2B). A wide range of viruses have been reported to activate the NF-κB pathway to 179 
promote virus replication, as NF-κB regulates numerous target genes involved in the host 180 
cell cycle and immune responses [19]. Interpretation of CAV infection data is complicated 181 
by the presence of integrated and circular copies of the MDV-1 genome [20]. MDV’s ICP4, 182 
pp38, and meq genes are involved in the maintenance of transformation of MSB-1 cells 183 
[21]. MDV miRNAs in MSB-1 cells target the mRNA of IL-18, a proinflammatory cytokine 184 
that stimulates IFN-γ production in T-cells [22]. Furthermore, NF-κB is central in MDV 185 
neoplastic transformation and the MDV Meq oncoprotein may augment NF-κB 186 
transcription by targeting the IKK complex [23]. The observed induction of the type II IFN 187 
response and the NF-κB complex in CAV-infected MSB-1 cells at 72 h (Fig. 2B) cannot be 188 
attributed to MDV, as normalised comparison between infected and mock samples should 189 
have negated any effect of MDV. However, whether aberrant signaling by MDV-proteins 190 
(undetectable by microarrays), can exacerbate the induction of NF-κB in the samples 191 
infected with CAV cannot be determined in this study. 192 
To identify inherent gene expression trends in the cells that may conceal or intensify CAV-193 
induced changes, such as an effect of the number of copies of MDV, we also compared the 194 
basal gene expression of mock MSB-1 cells across the time course (Fig. 2C and full dataset 195 
in Supplementary data). We did not observe DE genes involved in the NF-κB complex, but 196 
instead we identified a time-dependent upregulation (especially at 72 h) of proliferation- 197 
and apoptosis-related TGF-1 (consistent with the transformed phenotype of MSB-1 198 
cells) and downregulation of transcripts encoding chaperonin proteins (CCT4, HSPA8, 199 
HSP90B1), which ensure correct protein folding and prevent apoptosis [24]. CAV VP3 200 
requires a transformed environment to induce apoptosis [25], and the transformed 201 
phenotype of MSB-1 cells may offer an opportunistic advantage to VP3 and to CAV 202 
infection. Induction of pro-apoptotic genes (DEDD, DIDO1, CARD11) at 48 h and anti-203 
apoptotic genes (BIRC5 or inhibitor of apoptosis 5) at 72 h in CAV-infected cells compared 204 
to mock-infected (Fig. 2A) confirm that apoptosis is an integral part of the pathogenesis 205 
of the virus. Viruses have been reported to either induce or block apoptosis or do both at 206 
different stages during infection [26]. There is evidence that apoptosis is a prerequisite 207 
for CAV replication and facilitates virus escape from the cell [27, 28]. Nevertheless, it 208 
cannot be ruled out that the apoptosis seen is also part of a host defence mechanism to 209 
prevent CAV spread by early cell death [26].  210 
Combining IPA functional network analysis with differential gene expression analysis 211 
(Supplementary data) helped uncover high-confidence genes, such as SATB1, a 212 
pleiotropic genome organizer, which was downregulated at 72 h, and SLA, which inhibits 213 
TCR signaling [29] and was upregulated at 72 h p.i.. Both genes were found in our in vivo 214 
studies to be downregulated by CAV infection and were not found as differentially 215 
regulated by Crowley et al [13]. MSB-1 cells are distinct both functionally and 216 
phenotypically from lymphocytes in vivo and the virus-specific modulation of these genes 217 
both in vivo and in vitro implicates their involvement in a viral mechanism for suppression 218 
of host antiviral responses possibly by modulating host TCR-signaling, although this 219 
requires experimental confirmation.  220 
Validation of gene expression results by qRT-PCR demonstrated a high level of agreement 221 
in the measurement of expression of five randomly selected genes (SLA, TGF-1, SATB1, 222 
IFN-, STAT3) with both technologies (Pearson’s correlation coefficient r=0.987 and 223 
p=0.0018, Fig. 2D). For further validation of microarray results and for consistency with 224 
our previous in vivo study [6] we used qRT-PCR to examine the expression levels of 225 
transcripts for the signature pro-inflammatory (IL-1β, IL-2, IL-6, IL18 and CXCLi2 226 
(CAF/interleukin-8)), type I IFN (IFN-α and IFN-β), Th1 (Il-3, IL-12α, IL-12β and IFN-γ), 227 
Th2 (IL-4 and IL-13) and Treg (IL-10 and TGF-β4) cytokines. Only transcripts that showed 228 
significant differential expression are presented in Fig. 3. The results demonstrated subtle 229 
overall changes in the transcription of cytokines. At 24 h p.i. the expression of IFN-, TGF-230 
4 and IL-13 was moderately induced, while at 48 h we noticed a small but significant 231 
induction of IFN-, IFN-, TGF-4 and IL-3, followed by downregulation of these 232 
transcripts at 72 h. At 72 h the expression of only IL-1β was increased, while that of other 233 
cytokines was either unchanged (IL-6) or downregulated (IL-4, IL-10, IL-13, IL-18). 234 
Induction of IFN- and IFN- at 24 and 48 h is consistent with the observations of Crowley 235 
et al [13]. However, there is a discrepancy between their study, which reported that IL-2, 236 
IFN-, IL-12 and IL-12 were DE and our study, which did not detect any regulation in 237 
expression of these genes. In chickens, as in mammals, interferons are key modulators of 238 
immune response; they are induced following viral infection and initiate a signaling 239 
cascade through the Janus kinase signal transducer and activator of transcription (JAK-240 
STAT) pathway, leading to the transcriptional regulation of hundreds of IFN-regulated 241 
genes (IRGs), which induce an antiviral state in the cells [30-33]. However, analysis of our 242 
microarray results showed that host induction of IFN- at 24 h and IFN- and IFN- at 48 243 
h by CAV was not accompanied by differential expression of canonical chicken IRGs, such 244 
as Mx1, IFIT5, IFI6 and OASL at either 48 or 72 h. This together with the downregulation 245 
of IFN- and IFN- at 72 h suggest that both IFN induction and signaling cascades are 246 
efficiently blocked by the virus between 48-72 h. Future studies should aim to identify the 247 
mediators that CAV uses to disarm the host type-I IFN response. 248 
In this study, we used both qRT-PCR and an immune-focused microarray to screen host 249 
responses over 72 h of CAV infection in MSB-1 cells. While overall there was agreement 250 
with the gene expression trends described by Crowley et al [13], there were also many 251 
differences. These are possibly due to the lower MOI used in our study, and the more up-252 
to-date chicken genome annotation (Gallus gallus 5.0 assembly) that helped us identify 253 
new transcripts that may be involved in the pathogenicity of CAV. Crowley et al reported 254 
that CAV infection of MSB-1 cells resulted in an initial wave of inflammatory, anti-255 
apoptotic and anti-viral gene expression changes at 24 h, followed by alterations in genes 256 
associated with immunosuppression at 48 h. Instead, our study has showed minimal 257 
immune response at 24 h, a moderate antiviral response at 48 h and an increased 258 
regulation of NF-κB- and apoptosis- related transcripts at 72 h. Our results should prove 259 
helpful in elucidating the pathogenic mechanisms of CAV and for future work on CAV in 260 
MSB-1 cells i.e. RNA interference studies targeting CAV viral genes.  261 
 262 
Funding information 263 
This research was undertaken with the financial support of the Biotechnology and 264 
Biological Sciences Research Council (http://www.bbsrc.ac.uk) (grant numbers 265 
BBS/B/00182, BBS/B/00360 and BBS/B/0028X.  LR, DWB, EJG and PK were also 266 
supported by the BBSRC Institute Strategic Programme Grants (ISP3 Innate Immunity & 267 
Endemic Disease) [BB/J004227/1] and (ISP1 Analysis and Prediction in Complex Animal 268 
Systems) [BB/J004235/1]. ESG is currently supported by the BBSRC via grant 269 
BB/K002465/1 [“Developing Rapid Responses to Emerging Infections of Poultry 270 
(DDREVIP)”]. EJG is currently supported by BBSRC Strategic Programmes (ISP1 271 
Blueprints for Healthy Animals [BB/P013732/1]) and (ISP2 Control of Infectious 272 
Diseases [BB/P013740/1]). 273 
 274 
Acknowledgements 275 
Our thanks go to Kirsty Jensen for her technical assistance and advice, and to Dave 276 
Waddington who helped extensively with the data analysis.  277 
 278 
Conflict of interest 279 
We declare no conflicts of interest 280 
 281 
References: 282 
1. Todd D, McNulty MS. Circoviridae. In: Pattison M, McMullin PF, Bradbury JM, 283 
Alexander DJ (editors). Poultry diseases: Elsevier Health Sciences; 2008. pp. 398-404. 284 
2. Villiers E, Hausen HZ, Schat KA. Chicken Anemia Virus. In: de Villiers EM, zur 285 
Hausen H (editors). TT Viruses - Current Topics in Microbiology and Immunology: 286 
Springer Berlin Heidelberg; 2009. pp. 151-183. 287 
3. Bullenkamp J, Cole D, Malik F, Alkhatabi H, Kulasekararaj A et al. Human 288 
gyrovirus apoptin shows a similar subcellular distribution pattern and apoptosis 289 
induction as the chicken anaemia virus derived VP3/apoptin. Cell Death Dis 290 
2012;3:e296. 291 
4. Adair BM. Immunopathogenesis of chicken anemia virus infection. Dev Comp 292 
Immunol 2000;24:247-255. 293 
5. Jeurissen SH  Wagenaar F, Pol JM, van der Eb AJ, Noteborn MH. Chicken 294 
anemia virus causes apoptosis of thymocytes after in vivo infection and of cell lines after 295 
in vitro infection. J Virol 1992;66:7383-7388. 296 
6. Giotis ES, Rothwell L, Scott A, Hu T, Talbot R et al. Transcriptomic profiling of 297 
virus-host cell interactions following chicken anaemia virus (CAV) infection in an in vivo 298 
model. PLoS One 2015;10:e0134866. 299 
7. Todd D. Circoviruses: immunosuppressive threats to avian species: a review. 300 
Avian Pathol 2000;29:373-394. 301 
8. Coombes AL, Crawford GR. Chicken anaemia virus: A short review. Worlds Poult 302 
Sci J 1996;52:267-277. 303 
9. McNulty MS. Gordon Memorial Lecture. Chicken anaemia virus-a glimpse of the 304 
future? Br Poult Sci 1997;38:7-13. 305 
10. Noteborn MH, Koch G. Chicken anemia virus-infection-Molecular basis of 306 
pathogenicity. Avian Pathol 1995;24:11-31. 307 
11. Zanella A, Dall'Ara P, Lavazza A, Marchi R, Martin MA et al. Interaction 308 
between Marek's disease and chicken infectious anaemia viruses. Curr Prog Marek's Dis 309 
Res 2001:11-19. 310 
12. Haridy M, Goryo M, Sasaki J, Okada K. Pathological and immunohistochemical 311 
study of chickens with co-infection of Marek's disease virus and chicken anaemia virus. 312 
Avian Pathol 2009;38:469-483. 313 
13. Crowley TM, Haring VR, Moore R. Chicken anemia virus: An understanding of 314 
the in vitro host response over time. Viral Immunol 2011;24:3-9. 315 
14. Smith J, Speed D, Hocking PM, Talbot RT, Degen WG et al. Development of a 316 
chicken 5k microarray targeted towards immune function. BMC Genomics 2006;7:49. 317 
15.      Yuasa N. Propagation and infectivity titration of the Gifu-1 strain of chicken 318 
anemia agent in a cell-Line (MDCC-MSB1) derived from Mareks-disease lymphoma. Natl 319 
Inst Anim Health Q 1983;23(1):13-20. 320 
16. Yuasa N, Taniguchi T, Goda M, Shibatani M, Imada T et al. Isolation of chicken 321 
anemia agent with MDCC-MSB1 cells from chickens in the field. Natl Inst Anim Health Q 322 
1983;23:75-77. 323 
17. Vonbulow V, Fuchs B, Bertram M. Investigations on chicken infectious anemia 324 
Agent (CAA) in vitro - propagation, titration, serum neutralization tests, and indirect 325 
immunofluorescence assays. J Vet Med B Infect Dis Vet Public Health 1985;32:679-693. 326 
18. Kikkawa U, Matsuzaki H, Yamamoto T. Protein kinase C delta (PKC delta): 327 
Activation mechanisms and functions. J Biochem 2002;132:831-839. 328 
19. Hiscott J, Kwon H, Genin P. Hostile takeovers: viral appropriation of the NF-329 
kappa B pathway. J Clin Invest 2001;107:143-151. 330 
20. Rhiza HJ, Bauer B. Persistence of viral DNA in Marek’s disease virus-331 
transformed lymphoblastoid cell lines. In: Wittmann G, Gaskell RM, Rhiza HJ (editors). 332 
Latent herpesvirus infections in veterinary medicine. Boston, MA: Martinus Nijhoff; 1984. 333 
pp. 481–488. 334 
21. Xie Q, Anderson AS, Morgan RW. Marek's disease virus (MDV) ICP4, pp38, and 335 
meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-336 
transformed lymphoblastoid cells. J Virol 1996;70:1125-1131. 337 
22. Parnas O, Corcoran DL, Cullen BR. Analysis of the mRNA targetome of 338 
microRNAs expressed by Marek's disease virus. MBio 2014;5. 339 
23. Kumar S, Kunec D, Buza JJ, Chiang HI, Zhou HJ et al. Nuclear factor kappa B is 340 
central to Marek's disease herpesvirus induced neoplastic transformation of CD30 341 
expressing lymphocytes in vivo. BMC Systems Biol 2012;6. 342 
24. Didelot C, Schmitt E, Brunet M, Maingret L, Parcellier A et al. Heat shock 343 
proteins: endogenous modulators of apoptotic cell death. Handb Exp Pharmacol 344 
2006;172:171-198. 345 
25. Rohn JL, Zhang YH, Aalbers RI, Otto N, den Hertog J et al. A tumor-specific 346 
kinase activity regulates the viral death protein apoptin. J Biol Chem 2002;277:50820-347 
50827. 348 
26. Shen Y, Shenk TE. Viruses and apoptosis. Curr Opin Genet Dev 1995;5:105-111. 349 
27. Jeurissen SH, Wagenaar F, Pol JM, van der Eb AJ, Noteborn MH. Chicken 350 
anemia virus causes apoptosis of thymocytes after in vivo infection and of cell lines after 351 
in vitro infection. J Virol 1992;66:7383-7388. 352 
28.       Kaffashi A, Pagel CN, Noormohammadi AH, Browning GF. Evidence of 353 
apoptosis induced by viral protein 2 of chicken anaemia virus. Arch Virol 354 
2015;160:2557-2563. 355 
29. Myers MD, Dragone LL, Weiss A. Src-like adaptor protein down-regulates T cell 356 
receptor (TCR)-CD3 expression by targeting TCRzeta for degradation. J Cell Biol 357 
2005;170:285-294. 358 
30. Giotis ES, Robey RC, Skinner NG, Tomlinson CD, Goodbourn S et al. Chicken 359 
interferome: avian interferon-stimulated genes identified by microarray and RNA-seq of 360 
primary chick embryo fibroblasts treated with a chicken type I interferon (IFN-alpha). 361 
Vet Res 2016;47. 362 
31. Roll S, Hartle S, Lutteke T, Kaspers B, Hartle S. Tissue and time specific 363 
expression pattern of interferon regulated genes in the chicken. BMC Genomics 364 
2017;18:264. 365 
32.       Giotis ES, Ross CS, Robey RC, Nohturfft A, Goodbourn S et al. Constitutively 366 
elevated levels of SOCS1 suppress innate responses in DF-1 immortalised chicken 367 
fibroblast cells.  Sci Reports 2017;7. 368 
 369 
Figure legends 370 
 371 
Figure 1: Microarray analysis show distinct immune transcriptional profiles in CAV-372 
infected MSB-1 cells at 48 and 72 h p.i.. (A) Multidimensional scaling plot of microarray 373 
data that illustrates the pattern of proximities between the microarray datasets. Each spot 374 
represents the replicate samples for mock-infected (Mock -M) and CAV-infected (P) MSB-375 
1 cells at each time point. (B) Number of upregulated and downregulated genes in CAV-376 
infected compared with mock cells at each time point. Only genes showing statistical 377 
significance and a fold change ratio ≥ 1.5 were included. (C) Venn diagram of genes 378 
showing significant changes (and overlaps) in expression at 24, 48 and 72 h p.i. of MSB-1 379 
cells after infection with CAV.  380 
 381 
Figure 2: Microarray analysis shows that CAV-infected MSB-1 cells display a deregulated 382 
T-cell, proinflammatory and innate immune response. (A) The heatmap rendering of the 383 
indicated signalling pathways in mock- and CAV-infected cells. The ratios are a measure 384 
of relative gene expression at each time point compared to reference sample and are 385 
depicted according to the color scale shown on the bottom. (B) Ingenuity Pathway 386 
Analysis identified NF-κB as the top network signaling pathway at 72 h p.i. in CAV-infected 387 
cells. Green represents downregulation while red depicts upregulation while different 388 
node shapes represent functional classification. White nodes depict related or 389 
neighboring genes. Numbers below nodes denote fold change and significance values. 390 
Dotted and solid lines indicate indirect or physical cellular interaction between genes 391 
respectively. (C) Comparison of expression levels for 5 selected transcripts determined 392 
by microarray and qRT-PCR analysis. (D) Top five upregulated and downregulated genes 393 
in mock MSB-1 cells.  394 
 395 
Figure 3: qRT-PCR analysis of RNA samples from CAV-infected cells at 24, 48 and 72 h p.i. 396 
with a cytokine panel reveals modest transcription changes of immune related genes. 397 
Extracted total RNA of CAV-infected and mock-infected MSB-1 cells at each time point was 398 
subjected to reverse transcription followed by quantitative PCR using specific primer sets 399 
for 10 cytokines normalized against GAPDH (using the ΔΔCt method). Data are 400 
representative from three independent experiments. One-way ANOVA with Bonferroni 401 
posthoc test were used to analyse the data. *, P <0.05, **, P <0.01, ***, P < 0.001, ****, P < 402 
0.0001. Broken lines represent fold change=1. 403 
 404 
Supplementary data Full list of differentially regulated transcripts between mock-405 
infected and CAV-infected MSB-1 cells at 24, 48, 72 h p.i. and overlapping genes 406 
differentially regulated at both 48 and 72 h p.i. and differentially regulated transcripts 407 
between mock samples over time. Data enrichment information (Ingenuity pathway 408 
analysis) on Ingenuity canonical pathways and biological functions; Analyses include p-409 






24 h post infection results




desaturase FADS6 4.59 0.029102231 C0000360p16 1.17E-05 0.031213476
AM065821
 Protein 
kinase-delta1 PRKCD -1.53 0.044748184 C0000465g23 3.40E-05 0.040049625
48 h post infection results








6.91 0.044317654 C0000360h16 0.002369315 0.027033769
AM075291
Von Willebrand 
factor A domain 
containing 9
VWA9











TIAL1, TIAR) TIA1 4.33 0.02974712 C0000474i09 0.00113202 0.018145743
AM065949
 SEC31 
homolog B (S. 















(DNA directed) POLRMT 3.83 0.025543189 C0000463a04 0.000819107 0.015581345
AM066174
 death inducer-




homolog LIN37 3.39 0.02529927 C0000360i23 0.000805161 0.015493307
AM067986  porcupine PORCN 3.09 0.023730441 C0000476p07 0.000731483 0.014475569
BU457418  CD83 molecule CD83










IFNB) IFNB 2.72 0.030184133 IFNB gene 0.001172082 0.018412321
AM067700 B6.3 protein Bu-1 2.71 0.018827453 C0000476c12 0.000460652 0.011526558
AM063225
enoyl-CoA delta 






binding 1 TRAK1 2.37 0.003502086 C0000874m05 3.10E-05 0.002157519
AM071914















specific gene 1 
protein-like 
isoform 1 NMES1 2.11 0.008012217 C0000853o16 0.000105972 0.004898945
AM063112







(GLG1, CFR) GLG1 1.93 0.04923001 C0000360a11 0.00291675 0.030030306
AM069011
No Blast file 





variant X2 LOC101747338 1.89 0.010591731 C0000463n13 0.000175964 0.006561734
AM069035
protein 
FAM60A FAM60A 1.87 0.001133175 C0000873o12 4.31E-06 0.000691237
AM069842
 chromosome 4 
open reading 
frame, human 


























No Blast file 












2 COPG2 1.76 0.039041986 C0000485j07 0.001852072 0.023815612
AM063131
calcium binding 








member 2 ABCC2 1.74 0.01463354 C0000476j10 0.000292905 0.008926459














member 11 CARD11 1.73 0.000494955 C0000874m07 1.34E-06 0.000315186
AM067851
No Blast file 
found 1.72 0.010591731 C0000476j11 0.000174637 0.006490443











proliferative BTG1 1.71 0.044628196 C0000869i03 0.002456516 0.02736906
AM065873
MHC class II 
antigen MHC II 1.71 0.000297865 C0000465j08 5.40E-07 0.000181697
AM070074
heat shock 
70kDa protein 2 
(HSPA2, 
HSP70) HSPA2 1.69 0.000165127 C0000892a19 1.32E-07 0.000109484
AM071923
 zinc finger 




 death effector 
domain 










variant X JAGN1 1.64 0.002953584 C0000892i22 2.08E-05 0.001801687











7 GRK7 1.62 0.011856895 C0000877c23 0.000212544 0.007232706
AM067412
No Blast file 













(yeast) ACTR2 1.61 0.043558809 C0000873e10 0.002293028 0.026570874






protein MPV17 1.59 0.001260427 C0000476j04 6.56E-06 0.000812607
AM063124
vav 2 guanine 
nucleotide 
exchange factor VAV2 1.58 0.037311302
BET603945395
M23 0.001732631 0.022759894









chain, S and C 
regions HB-15 1.56 0.047511368 C0000476b12 0.002710316 0.028981934






(IFRD1, IFR1) IFRD1 1.56 0.015046502 C0001705E24 0.000304183 0.009178366










protein 31 ARHGAP31 1.52 0.000297865 C0000464j22 5.96E-07 0.000182778
AM069195
heat shock 
70kDa protein 8 
(HSPA8, 


































-1.54 0.001260427 C0000463f03 6.40E-06 0.000784626
AM063132
tubulin-folding 





family 7 (amino 
acid transporter 
light chain, L 
system), 













recycling factor MRRF -1.57 0.000833736 C0000641A17 3.00E-06 0.000508579
AM065826
 heme binding 
protein 2 HEBP2 -1.58 0.000493909 C0000465h05 1.09E-06 0.000301285
AM072025
YTH domain 








variant X8 ZBTB46 -1.58 0.016501636 C0000465p04 0.000347292 0.010065998
AM066494 CXXC5 CXXC5 -1.60 0.026415653 C0000468h15 0.000885358 0.016113548
AM070525
 SH3 and PX 
domains 2A SH3PXD2A -1.62 0.031639637 C0001683B19 0.00130351 0.019337075
AM064451 ring finger and 
CHY zinc finger 






ALASN) ALAS1 -1.66 0.000179482 C0000474b09 1.80E-07 0.000121936
AM065819
 ATPase, class 
















isoform 2 TLK2 -1.70 0.008012217 C0000467k24 0.000109053 0.004954872
AM066657
Meis homeobox 
1 MEIS1 -1.70 0.038469591 C0000468o24 0.001817218 0.02346645
AM063478
apolipoprotein 







D RRAGD -1.74 0.004247716
UEB603580980
O19 4.25E-05 0.002621548





variant X2 UBAC1 -1.76 0.040007229 C0000858e15 0.001977939 0.024468877
AM064389
 chromosome 3 
open reading 
frame, human 
C20orf196 C3H20orf196 -1.77 0.003034972 C0000858l15 2.25E-05 0.001861649
AM069042
 high mobility 
group protein 










(MFAP1, AMF) MFAP1 -1.83 0.021166543 C0000463b07 0.000607322 0.012911591
AM071877
argininosuccina
te synthase 1 ASS1 -1.86 0.045160636
CHK02000039b
19 0.002503902 0.027642186
AM065828 TRMT1L TRMT1L -1.87 0.00074841 C0000465h07 2.40E-06 0.00045653
AM066098
uncharacterized 
LOC107057081 LOC107057081 -1.89 0.032689338 C0000467e07 0.001402686 0.019940496
AM065719
 transmembran
e protein 86A TMEM86A -1.91 0.009592759 C0000465c03 0.000153607 0.005851583
AM066626
ankyrin repeat 
and SOCS box 
containing 6 
ASB6
-1.97 0.003067068 C0000468n14 2.46E-05 0.001923865
AM066471
 vestigial like 1 
















 ring finger 
protein 213 RNF213 -2.53 0.004368754 C0000468o22 4.46E-05 0.00266494
AM072018
MHC class II 
antigen B-F 
minor heavy 




 collagen, type 








1 LSP1 -4.73 0.001133619 C0001683C14 4.99E-06 0.000717583
72 h post infection results




homolog A (MAFA, L-MAF, 
MAFL)
L-MAF 2.55 0.02810402 C0000464f04 0.005282 0.01301216





SNRPE 2.40 1.90E-09 C0000853h10 1.14E-12 8.79E-10
AM068465  nucleophosmin/nucleoplasm
in 3
NPM3 2.34 7.86E-07 C0000869e16 4.35E-09 3.64E-07
AM070721  tubulin, alpha 1c TUBA1C 2.31 5.43E-08 C0000798c21 6.53E-11 2.52E-08
AM064778 ribonucleotide reductase M1 RRM1 2.21 1.35E-07 C0000360g20 3.52E-10 6.26E-08
AM069195 heat shock 70kDa protein 8 
(HSPA8, HSC70)
HSPA8 2.19 9.85E-07 C0000874f21 6.31E-09 4.56E-07
AM067522  coiled-coil domain 
containing 90B
CCDC90B 2.18 0.03408799 C0000474k03 0.006809 0.01578274
AM071776  nicotinamide riboside kinase 
2-like
NMRK2 2.16 9.85E-08 C0000222n02 2.17E-10 4.77E-08
AM068181  tubulin alpha-4A chain-like TUB4A 2.14 2.01E-07 C0000485i01 6.83E-10 9.29E-08
AM064344 proliferating cell nuclear 
antigen 
PCNA 2.11 2.21E-08 C0000858j11 2.22E-11 1.03E-08
AM065483
serum response factor (c-fos 
serum response element-
binding transcription factor) 
SRF 2.10 5.82E-05 C0000464g24 1.53E-06 2.70E-05
AM065980  thimet oligopeptidase-like TOP 2.09 8.22E-07 C0000465o16 4.77E-09 3.81E-07
AM068994  ribonucleotide reductase M2 RRM2 2.07 1.80E-09 C0000873m1
6
7.22E-13 8.35E-10
AM064025 src-like-adapter (SLA, TG) SLA 2.07 7.27E-08 C0000856i08 1.24E-10 3.36E-08
AM067991
eukaryotic translation 
initiation factor 2, subunit 1 
alpha, 35kDa 
EIF2S1 2.05 0.00108892 C0000476p12 6.97E-05 0.00050417
AM065982
solute carrier family28 
(sodium-coupled nucleoside 
transporter), member2
SLC28A2 2.03 0.01205274 C0000465o18 0.001703 0.00558042





AM065940 slit homolog 1 (Drosophila) SLIT1 1.99 2.33E-05 C0000465m1
9
4.56E-07 1.08E-05
AM064375 Lysine (K)-specific 
demethylase 5A
KDM5A 1.99 1.08E-06 C0000858k22 7.55E-09 5.00E-07
AM066456
xeroderma pigmentosum, 
complementation group A 
(XPA, XPAC)
XPA 1.98 0.02346307 C0000468f23 0.004147 0.0108634
AM075275 cyclin-dependent kinase 2 CDK2 1.97 0.00019279 CHK0200003
9g09
7.02E-06 8.96E-05
AM066590  zinc finger protein 650 ZNF650 1.96 0.00081181 C0000468l21 4.68E-05 0.00037587
AM066237 haperonin containing TCP1, 
subunit 4 (delta) 
CCT4 1.96 5.41E-07 C0000467l04 2.60E-09 2.56E-07
AM068963 chromodomain helicase DNA 
binding protein 7 
CHD7 1.94 6.01E-06 C0000873l07 7.34E-08 2.78E-06
AM066378 PREDICTED: ras-related 
protein Rab-44-like
RAB44 1.94 2.67E-06 C0000468c09 2.51E-08 1.24E-06
AM071012
 processing of precursor 5, 
ribonuclease P/MRP subunit 
(S. cerevisiae)
POP5 1.93 0.0008324 C0000853b06 4.87E-05 0.0003854
AM070689 glutathione S-transferase 
omega 1 
GSTO1 1.92 0.00035902 C0000798b11 1.59E-05 0.00016623
AM066433 adhesion regulating 
molecule 1 










LOC107049794 1.89 0.00027954 C0000856k01 1.11E-05 0.00012943
AM069815
baculoviral IAP repeat 
containing 5 (BIRC5, 
survivin)
BIRC5 1.88 0.00013162 C0000878e01 4.29E-06 6.09E-05
AM064767 family with sequence 
similarity 96, member A
FAM96A 1.86 5.14E-06 C0000360g07 5.66E-08 2.38E-06
AM064640 phosphatidylinositol glycan 
anchor biosynthesis, class T
PIGT 1.86 0.0014721 C0000360a13 0.000106 0.00068158
AM065835 structure specific recognition 
protein 1 
CIIDBP 1.84 0.00018102 C0000465h14 6.38E-06 8.38E-05
AM066813  acyl-CoA synthetase family 
member 2
ACSF2 1.83 0.00022246 GCX6039455
11E03
8.28E-06 0.000103
AM067040 lanosterol 14-alpha 
demethylase
CYP51A1 1.83 0.00279517 C0000473d02 0.000242 0.0012971
AM063713
nuclear casein kinase and 
cyclin-dependent kinase 
substrate 1 (NUCKS1, JC7, 
NUCKS)




signal transducer and 
activator of transcription 3 
(acute-phase response 
factor) 





macropain) subunit, alpha 
type, 3 
PSMA3 1.81 9.06E-07 C0000798a04 5.58E-09 4.19E-07
AM064656  protein MANBAL-like LOC431205 1.80 1.87E-07 C0000360b05 5.63E-10 8.68E-08
AM068185
 fatty acyl-CoA hydrolase 
precursor, medium chain-like LOC415787 1.80 2.22E-05 C0000485i05 4.26E-07 1.03E-05
AM063593
 ArfGAP with RhoGAP 






 ADAM metallopeptidase 
with thrombospondin type 1 
motif, 7
ADAMTS7 1.79 1.07E-06 C0000798a06 7.07E-09 4.95E-07
AM071781 lectin, galactoside-binding, 
soluble, 3




polypeptides B and B1 
(SNRPB, SNRB', SNRPB')
SNRPB 1.79 1.19E-07 C0000856g03 2.87E-10 5.52E-08
AM063974  ADP-ribosylation factor 4 ARF4 1.79 1.69E-05 C0000856f10 2.91E-07 7.82E-06
AM069279 heat shock 70kDa protein 8 
(HSPA8, HSC70)
HSPA8 1.78 0.00029522 C0000874j18 1.19E-05 0.00013669
AM065606 Protein MEF2BNB isoform 1 MEF2BNB 1.77 1.48E-06 C0000464m1
2
1.21E-08 6.85E-07
AM067164 uracil-DNA glycosylase UNG 1.76 7.23E-05 C0000473j02 1.98E-06 3.38E-05
AM063229 heat shock 70kDa protein 8 
(HSPA8, HSC70)
HSPA8 1.76 3.45E-05 HFU6035513
20G05
7.88E-07 1.60E-05
AM064943  fms-related tyrosine kinase 
3
FLT3 1.76 0.0013228 C0000360o06 9.08E-05 0.00061246
AM071746 thymosin beta 15 TMSB15 1.75 0.00365866 C0000222l16 0.000339 0.00169396
AM063920 No Blast file found 1.74 0.00057849 C0000856b24 2.85E-05 0.0002686
AM063779
nuclear factor of kappa light 
polypeptide gene enhancer 
in B-cells 1 (NFKB1, NF-
KB1)




 leucine rich repeat and 
sterile alpha motif containing 
1
LRSAM1 1.74 9.89E-06 C0000468g21 1.48E-07 4.58E-06
AM069568 tubulin, beta 2C TUBB2C 1.73 7.86E-07 C0000877h22 4.41E-09 3.72E-07
AM066661 chromatin accessibility 
complex 1 
CHRAC1 1.73 0.00041668 C0000468p05 1.91E-05 0.00019292





TRAIL-LIKE 1.72 4.48E-05 C0000467e14 1.08E-06 2.08E-05
AM065943 dynein, light chain, Tctex-
type 1
DYNLT1 1.71 0.01405168 C0000465m2
2
0.002095 0.00650593
AM063885 cyclin-dependent kinase 1 
(CDK1, CDC2)
CDK1 1.71 3.26E-07 C0000856a04 1.30E-09 1.58E-07
AM065320 fasciculation and elongation 
protein zeta 1 (zygin I)
FEZ1 1.71 7.93E-06 C0000463p14 1.06E-07 3.67E-06
AM066137
 high mobility group 
nucleosome binding domain 
5
HMGN5 1.70 1.95E-07 C0000467g04 6.24E-10 9.01E-08
AM070678 peptidylprolyl isomerase H 
(cyclophilin H) 
PPIH 1.70 1.35E-05 C0000798a23 2.26E-07 6.27E-06
AM065999 phosphoglycerate mutase 1 
(brain) 
PGAM1 1.69 2.91E-05 C0000465p11 6.17E-07 1.35E-05








AM064972  signal recognition particle 
receptor subunit beta-like
SRPRB 1.68 0.00272515 C0000360p13 0.000232 0.00126174
AM065433
 smg-8 homolog, nonsense 
mediated mRNA decay 
factor (C. elegans)
SMG8 1.67 3.55E-06 C0000464e20 3.62E-08 1.64E-06
AM064662 FK506 binding protein 3, 
25kDa 
FKBP3 1.67 7.53E-06 C0000360b12 9.94E-08 3.48E-06
AM066530
 platelet-derived growth 
factor receptor, beta 
polypeptide
PDGFRB 1.67 1.06E-05 C0000468j04 1.63E-07 4.90E-06
AM072052 acetyl-CoA acetyltransferase 
2 















IMPDH2 1.65 9.63E-06 C0000360e07 1.41E-07 4.46E-06
BU438017




MIF 1.65 0.00146059 604141521F1 0.000104 0.00067625
AM067325 uncharacterized 
LOC107051754 
LOC107051754 1.64 0.04062212 C0000474a13 0.008611 0.01880804
AM063607 transmembrane protein 60 
(TMEM60, C7orf35)
TMEM60 1.64 3.05E-06 BET60394536
4O15
2.99E-08 1.41E-06
AM066591 PREDICTED: Nipped-B 
homolog
NIPBL 1.64 0.01364428 C0000468l22 0.00201 0.0063173
AM072144 chaperonin containing TCP1, 
subunit 7 (eta)




small subunit (SSU) 
processome component 
homolog (yeast)
UTP20 1.64 0.00372292 C0000467c24 0.000348 0.00172371
AM070729  beta-1,4-N-acetyl-
galactosaminyl transferase 3
B4GALNT3 1.63 0.00346155 C0000798d07 0.000312 0.0016027
AM066027  mitochondrial amidoxime 
reducing component 2
Mar-02 1.63 0.01150941 C0000467a19 0.001599 0.00532886
AM069690 flap structure-specific 
endonuclease 1 
FEN-1 1.63 0.00026742 C0000877n11 1.05E-05 0.00012382
AM065149  mannosidase, alpha, class 
1B, member 1
MAN1B1 1.63 0.00030793 C0000463h19 1.28E-05 0.00014282
AM064729 UPF0454 protein C12orf49 
homolog precursor
C12orf49 1.63 0.02092164 C0000360e15 0.003551 0.00969279
AM063749
 carbamoyl-phosphate 
synthetase 2, aspartate 
transcarbamylase, and 
dihydroorotase
CAD 1.63 0.00030642 ODP6039457
43E11
1.26E-05 0.00014254
AM063980 mitogen-activated protein 
kinase kinase kinase 3





TECPR1 1.62 9.06E-07 C0000463p19 5.62E-09 4.30E-07
BU294744
interferon gamma receptor 2 
(interferon gamma 
transducer 1) 
IFNGR2 1.62 0.03192204 603606133F1 0.006236 0.0147799
AM065840
phospholipase A2, group VII 
(platelet-activating factor 
acetylhydrolase, plasma) 
PLA2G7 1.62 4.12E-07 C0000465h19 1.73E-09 1.91E-07
AM064952  enoyl CoA hydratase 1, 
peroxisomal
ECH1 1.61 5.42E-06 C0000360o15 6.07E-08 2.51E-06
AM071894 SEC62 homolog (S. 
cerevisiae) (SEC62, TLOC1)




ATPase, H+ transporting, 
lysosomal V0 subunit a1 
(ATP6V0A1, A1)
ATP6V0A1 1.61 2.01E-05 C0000468l23 3.70E-07 9.37E-06
AM064802
adaptor-related protein 
complex 1, gamma 1 subunit 
(), transcript variant X2
AP1G1 1.61 0.00013544 C0000360h21 4.47E-06 6.30E-05
AM072086 primary ciliary dyskinesia 
homolog (mouse)
DPCD 1.60 0.00063746 CHK0200003
9l12
3.28E-05 0.00029515
AM066004  FtsJ methyltransferase 
domain containing 2
FTSJD2 1.60 7.07E-05 C0000465p16 1.90E-06 3.27E-05
AM065572 LIM domain kinase 2 
(LIMK2,LIMK)
LIMK2 1.60 7.23E-05 C0000464k22 1.98E-06 3.37E-05
AM065886
N(alpha)-acetyltransferase 
25, NatB auxiliary subunit 
(NAA25, C12orf30)
NAA25 1.60 0.0018008 C0000465j24 0.000138 0.00083377
AM065814  NEDD4 binding protein 2-
like 1
N4BP2L1 1.59 0.00545842 C0000465g16 0.000583 0.00252725
AM067252 SET nuclear oncogene SET 1.59 2.16E-05 C0000473n05 4.07E-07 1.00E-05
AM064871  integrator complex subunit 
12
INTS12 1.59 4.48E-05 C0000360l01 1.08E-06 2.07E-05
AM065243 No Blast file found 1.59 0.01496141 C0000463l22 0.002282 0.00693597
AM068034 deoxythymidylate kinase 
(thymidylate kinase) 
DTYMK 1.59 7.85E-07 C0000485b10 4.08E-09 3.63E-07





macropain) subunit, alpha 
type, 2 
PSMA2 1.58 1.33E-05 C0001672A20 2.18E-07 6.16E-06
AM069763 microcephalin 1 MCPH1 1.58 0.01715687 C0000878b09 0.002716 0.00794613
AM066313 cystatin C CST3 1.58 2.42E-07 C0000467o22 8.71E-10 1.12E-07
AM071734
 KH domain containing, RNA 
binding, signal transduction 
associated 3
KHDRBS3 1.58 0.01198724 C0000222l03 0.001689 0.00555009
AM065085  BCL2-associated 
athanogene 2





SNRPD3 1.57 7.33E-06 C0000222j10 9.53E-08 3.39E-06
AM066144
golgi to ER traffic protein 4 
homolog (S. cerevisiae) 
(GET4, C7orf20)
GET4 1.57 0.00010313 C0000467g12 3.14E-06 4.78E-05
AM072222
NOP56 ribonucleoprotein 
homolog (yeast) (NOP56, 
NOL5A)
NOP56 1.57 0.00043438 3L03 2.04E-05 0.00020148
AM075321 No Blast file found 1.57 2.00E-06 C0000467g16 1.80E-08 9.25E-07
AM071803 zinc finger, matrin type 5 ZMAT5 1.56 0.00701641 C0000222o09 0.000812 0.0032526
AM064370  LYR motif containing 5 LYRM5 1.56 0.00569013 C0000858k16 0.000615 0.00263453
AM070725  tripartite motif containing 25 TRIM25 1.56 0.0045122 C0000798d01 0.000447 0.0020951
AM064149
LOC100859089; GINS 
complex subunit 1 (Psf1 
homolog) 
GINS1 1.56 0.01018681 C0000856p11 0.001357 0.00471649
AM067023 progressive external 
ophthalmoplegia 1 
PEO1 1.56 0.00076356 C0000473b21 4.30E-05 0.00035353
AM066474 hydroxyacylglutathione 
hydrolase-like 
HAGHL 1.56 9.10E-06 C0000468g17 1.27E-07 4.24E-06
AM069131
 nuclear autoantigenic sperm 
protein (histone-binding) NASP 1.56 0.00140724 C0000874c22 9.83E-05 0.00065155
AM067279
LSM7 homolog, U6 small 
nuclear RNA associated (S. 
cerevisiae)
LSM7 1.55 0.00214943 C0000473o09 0.000172 0.00099519
AM065676 DnaJ (Hsp40) homolog, 
subfamily C, member 17 
DNAJC17 1.55 0.00151468 C0000464p14 0.00011 0.0007013
AM075355  patched domain containing 
1
PTCHD1 1.55 0.00303982 C0000476d12 0.000265 0.00140743
AM064189  nucleoporin 214kDa NUP214 1.55 0.00326288 C0000858b12 0.00029 0.00151071
AM064811
phenylalanyl-tRNA 
synthetase, alpha subunit 
(FARSA, FARSLA, PheRS)
FARSA 1.55 0.00349249 C0000360i06 0.000317 0.00161989
AM071846 mu immunoglobulin heavy 
chain C region
IGHM 1.55 2.85E-06 CHK0200003
9a10
2.74E-08 1.32E-06
AM070849  TLC domain containing 1 TLCD1 1.55 0.01649364 C0000798j06 0.002582 0.00763655
AM068974 CD48 molecule CD48 1.54 5.41E-07 C0000873l19 2.55E-09 2.56E-07
AM066305 arginyl-tRNA synthetase 
(RARS, LOC416169)
RARS 1.54 1.70E-05 C0000467o14 2.97E-07 7.89E-06
AM065074 LOC422497 LOC422497 1.54 0.01334431 C0000463e14 0.00195 0.00617841
AM066441 PREDICTED: complement 
receptor type 2-like
CR2 1.54 0.00798439 C0000468f07 0.000986 0.00370042
AM066543  phosphotyrosine 
phosphatase kappa-like
TROJAN 1.53 0.00166149 C0000468j18 0.000122 0.00076927
AM070267
heterogeneous nuclear 
ribonucleoprotein D (AU-rich 
element RNA binding protein 
1, 37kDa)






DLST 1.53 0.00195253 C0000467h08 0.000153 0.00090402
AM066593  IQ motif containing GTPase 
activating protein 1
IQGAP1 1.53 0.00238144 C0000468l24 0.000194 0.00110261
AM066381 RAB19, member RAS 
oncogene family 
RAB19 1.53 0.00451888 C0000468c12 0.00045 0.00209691
AM063336  charged multivesicular body 
protein 3





6) domain family member 2 RASSF2 1.53 1.83E-06 C0000464i20 1.57E-08 8.45E-07
AM070342 transmembrane protein 57 TMEM57 1.52 0.00391344 C0000892m1
4
0.000373 0.00181192
AM069890  polymerase (DNA directed), 
delta 2, accessory subunit
POLD2 1.52 0.0061223 C0000878h16 0.000681 0.00283463
AM069085
eukaryotic translation 
initiation factor 2B, subunit 2 
beta, 39kDa 
EIF2B2 1.52 1.88E-06 C0000874a18 1.66E-08 8.72E-07
AM064835
 nuclear factor of kappa light 
polypeptide gene enhancer 
in B-cells inhibitor, epsilon
NFKBIE 1.52 1.06E-05 C0000360j08 1.65E-07 4.97E-06
AM068831 CD80 molecule CD80 1.52 0.01187223 C0000873f07 0.001668 0.00549816
AM064727 LOC100859660 LOC100859660 1.52 0.04114974 C0000360e13 0.008772 0.01905233
AM066145  ADP-dependent glucokinase ADPGK 1.52 2.28E-05 C0000467g13 4.42E-07 1.05E-05
AM070108 brain protein 44-like BRP44L 1.51 0.00826854 C0000892c07 0.001028 0.00382834
AM072094 heat shock 70kDa protein 8 
(HSPA8, HSC70)
HSPA8 1.51 0.00025242 CHK0200003
9l21
9.74E-06 0.00011687
AM069616 nuclear distribution C 
homolog (A. nidulans) 





 KCTD3 1.51 0.00264099
GCX6039456
22K06 0.000223 0.00122284
AM065570  mbt domain containing 1 MBTD1 1.51 9.84E-06 C0000464k20 1.46E-07 4.55E-06
AM066162 ZPLD1 ZPLD1 1.51 0.00566703 C0000467h11 0.00061 0.00262384
AM070730 death associated protein 3 DAP3 1.51 0.00558867 C0000798d08 0.000598 0.00258755
AM069986 member RAS oncogene 
family (RAN, RANP1)
RAN 1.50 6.06E-06 C0000878m1
3
7.52E-08 2.81E-06
AM067693  death effector domain 
containing
DEDD 1.50 0.00516045 C0000476c05 0.000539 0.00238929
AM065891
nudix (nucleoside 
diphosphate linked moiety X)-
type motif 21 
NUDT21 1.50 1.15E-06 C0000465k07 8.99E-09 5.33E-07
AM067418  neural proliferation, 
differentiation and control 1
NPDC1 -1.50 1.11E-05 C0000474f02 1.80E-07 5.14E-06
AM064613 zyxin ZYX -1.50 1.06E-05 C0001620N16 1.65E-07 4.94E-06
AM068454
TIA1 cytotoxic granule-
associated RNA binding 
protein (TIA1, TIAL1, TIAR)
TIA1 -1.50 0.04235822 C0000869e05 0.009106 0.01961186
AM067768  ribosomal protein L10a RPL10A -1.50 3.87E-05 C0000476f17 9.09E-07 1.79E-05
AM069256 LOC101749469 LOC101749469 -1.50 1.35E-05 C0000874i16 2.28E-07 6.30E-06
AM065004 eukaryotic translation 
initiation factor 2C, 4 
EIF2C4 -1.51 0.00029525 C0000463b08 1.20E-05 0.0001367
AM066525 F-box protein 9 FBXO9 -1.51 0.00115663 C0000468i22 7.64E-05 0.0005369
AM067296
retinoic acid receptor 
responder (tazarotene 
induced) 1 (RARRES1, 
OCX32)
RARRES1 -1.51 0.04295785 C0000473p03 0.009295 0.01988949
AM071638 LOC417345 LOC417345 -1.51 0.00099287 C0000222g08 6.23E-05 0.0004597
AM069542 No blast file found -1.51 2.91E-05 C0000877g19 6.17E-07 1.35E-05
AM065123 collagen, type V, alpha 1 
(COL5A1, cha1V)
COL5A1 -1.52 8.34E-06 C0000463g16 1.13E-07 3.86E-06
AM066724 proline-rich nuclear receptor 
coactivator 1 
PNRC1 -1.52 7.02E-05 C0000645F18 1.87E-06 3.25E-05
AM069080  zinc finger CCCH-type 
containing 7B
ZC3H7B -1.52 4.83E-05 C0000874a13 1.21E-06 2.24E-05
AM064339 insulin induced gene 1 INSIG1 -1.52 0.00086741 C0000858j05 5.16E-05 0.00040161
AM066172  anaphase promoting 
complex subunit 2
ANAPC2 -1.52 1.61E-05 C0000467i01 2.74E-07 7.47E-06
AM065476  EPS8-like 2 EPS8L2 -1.52 0.00229954 C0000464g17 0.000187 0.00106526
AM071717 DEAD (Asp-Glu-Ala-Asp) 
box helicase 17 
DDX17 -1.53 0.00018526 C0000222k10 6.56E-06 8.58E-05
AM068035  sequestosome 1 SQSTM1 -1.53 7.23E-05 C0000485b11 1.98E-06 3.35E-05
AM075339 No blast file found -1.53 7.29E-06 C0000473l23 9.34E-08 3.38E-06
AM064675 major vault protein MVP -1.54 0.0016688 C0000360c03 0.000124 0.00077368
AM067754  K(lysine) acetyltransferase 5 KAT5 -1.54 0.00581287 C0000476f01 0.000632 0.00269554
AM069278
CD247 molecule (CD247, 





AM069768 purinergic receptor P2Y, G-
protein coupled, 10
P2RY10 -1.55 0.00035455 C0000878b14 1.55E-05 0.00016416
AM067389 Der1-like domain family, 
member 3 
DERL3 -1.55 0.01603639 C0000474d14 0.002494 0.00742485
AM067934 calpain 2, (m/II) large subunit CAPN2 -1.55 0.01917793 C0000476n02 0.00317 0.00887938
AM066186
Ras association (RalGDS/AF-





HHEX -1.56 0.02071854 C0000465d01 0.003479 0.00959268
AM067846 Glyceraldehyde 3-phosphate 
dehydrogenase
GAPDH -1.56 1.10E-05 C0000476j06 1.75E-07 5.08E-06
AM069035 protein FAM60A FAM60A -1.56 0.0038406 C0000873o12 0.000364 0.0017782
AM071226  transmembrane protein 35-
like
TMEM35 -1.56 0.01025036 C0000853l17 0.001375 0.00474768
AM070235
PREDICTED: microtubule-
actin cross-linking factor 1, 
isoforms 1/2/3/5-like, partial
MACF1 -1.57 7.88E-05 C0000892h24 2.23E-06 3.65E-05
AM069010 spermidine/spermine N1-
acetyltransferase 1
SAT1 -1.57 3.74E-06 C0000873n10 3.89E-08 1.73E-06
AM072025 YTH domain containing 1 YTHDC1 -1.58 0.00540719 CHK0200003
9i20
0.000575 0.00250353
AM065039 melanoma inhibitory activity 
family, member 3 
MIA3 -1.58 0.02203165 C0000463c20 0.003797 0.01020065
AM065752 zinc finger CCCH domain-
containing protein 11A
ZC3H11A -1.58 2.41E-05 C0000465d14 4.84E-07 1.11E-05
AM064118 runt-related transcription 
factor 1 




specific gene 1 protein-like 
isoform 1
NMES1 -1.59 0.0409644 C0000853o16 0.008722 0.0189832
AM072184  post-GPI attachment to 
proteins factor 2-like
PGAP2 -1.60 0.0224882 CHK0200003
9p22
0.003912 0.01041204
AM066970  glutamate dehydrogenase 1 GLUD1 -1.60 0.00093935 JYM60394608
6K22
5.79E-05 0.00043492
AM068467 ChaC, cation transport 
regulator homolog 1 (E.coli) 
CHAC1 -1.60 4.49E-05 C0000869e18 1.10E-06 2.08E-05
AM063372















 LOC769674 -1.63 0.00012143 C0000650I10 3.86E-06 5.62E-05
AM065818  oncoprotein induced 
transcript 3
OIT3 -1.64 0.03834609 C0000465g20 0.008051 0.01775424
AM075540 No blast file found -1.64 0.00144386 C0000856b07 0.000102 0.00066851
AM065026 SET domain containing 
(lysine methyltransferase) 8
 SETD8 -1.65 0.00440032 C0000463c07 0.000428 0.00203735
AM065878 PREDICTED: tripeptidyl-
peptidase 1
TPP1 -1.66 0.00882726 C0000465j13 0.001133 0.00408702
AM069042  high mobility group protein 
HMGI-C-like
HMGI-C -1.66 0.00415173 C0000873o19 0.0004 0.00192225
AM067821
 WD repeat domain, 
phosphoinositide interacting 
1
WIPI1 -1.66 0.0021321 C0000476i02 0.00017 0.00098716
AM064390  tumor protein p53 inducible 
nuclear protein 2
TP53INP2 -1.67 7.27E-08 C0000858l16 1.31E-10 4.11E-08
AM067131  ras homolog family member 
H
RhoH -1.67 1.10E-05 C0000473h10 1.76E-07 5.11E-06
AM071706 glutamate receptor, 
ionotropic, AMPA 1 
GRIA1 -1.68 1.74E-07 C0000222j22 4.86E-10 8.04E-08
AM067786 tumor protein p53 inducible 
nuclear protein 1 
TP53INP1 -1.68 0.04511224 C0000476g12 0.009978 0.02088697
AM068392 uncharacterized 
LOC107052719, transcript 
LOC107052719 -1.68 0.03160725 C0000869b12 0.006162 0.01463416
AM064686
A kinase (PRKA) anchor 
protein (yotiao) 9 (AKAP9, 
HYPERION)
AKAP9 -1.69 0.01675445 C0000360c18 0.002639 0.00775731
AM065075 adenosine kinase ADK -1.70 0.02247363 C0000463e15 0.003905 0.01040529
AM066490
elastin (supravalvular aortic 
stenosis, Williams-Beuren 
syndrome)





CHD3 -1.70 0.0126928 C0000464n23 0.001811 0.00588183
AM075534 LOC101751004 LOC101751004 -1.71 1.27E-06 C0000853o06 1.01E-08 5.86E-07
AM066244
tumor necrosis factor 
receptor superfamily, 









protein phosphatase C 
precursor
PTPRC -1.71 0.00010818 C0000465c01 3.36E-06 5.02E-05
AM063908 adenosine deaminase ADA -1.72 0.00068226 C0000856b08 3.70E-05 0.00031771
AM067189
dishevelled-binding 
antagonist of beta-catenin 1 , 
transcript variant X4
DACT1 -1.72 0.01859562 C0000473k05 0.003029 0.00860977
AM064646  TRAF2 and NCK interacting 
kinase
TNIK -1.72 0.00169786 C0000360a19 0.000127 0.00078611
AM065516 noggin 2 NOG2 -1.72 0.01364518 C0000464i11 0.002018 0.0063258
AM064649  paramyosin-like LOC420107 -1.73 0.04201484 C0000360a22 0.009007 0.01945287
AM068079 PRELI domain containing 1 PRELID1 -1.75 1.08E-06 C0000485d12 7.78E-09 5.10E-07
AM071281 No blast file found -1.75 5.61E-06 C0000853o08 6.74E-08 2.64E-06
AM066422
integrin, beta 2 (complement 
component 3 receptor 3 and 












solute carrier family 7 (amino 







AM069691 DHHC-type containing 18, 
transcript variant X3
ZDHHC18 -1.77 0.00115663 C0000877n13 7.64E-05 0.00053689
AM066236 LOC427029 uncharacterised 
protein
LOC427029 -1.78 0.01536451 C0000467l03 0.002368 0.00711923
AM071587  unc-51-like kinase 2 (C. 
elegans)
ULK2 -1.80 0.00075913 C0000222d21 4.25E-05 0.00035148
AM064991
ceroid-lipofuscinosis, 
neuronal 8 (epilepsy, 
progressive with mental 
retardation)
CLN8 -1.80 0.04297192 C0000463a15 0.009313 0.019896
AM066521  sulfotransferase family 
cytosolic 2B member 1-like
LOC415852 -1.81 0.03244743 C0000468i18 0.006356 0.01503235
AM066053  EGF-like-domain, multiple 7 EGFL7 -1.82 0.02791065 C0000467c04 0.005226 0.01292621
AM066790 Actin, gamma2 ACTG2 -1.82 9.10E-06 C0000653P03 1.26E-07 4.21E-06
AM065230 KIAA1462 KIAA1462 -1.84 0.03614674 C0000463l08 0.007409 0.01673594
AM071676  BCL2-like 14 (apoptosis 
facilitator)
BCL2L14 -1.84 0.01204928 C0000222h23 0.0017 0.00557882
AM064738 CD3d molecule, delta (CD3-
TCR complex)
CD3D -1.86 1.57E-06 C0000360f01 1.32E-08 7.26E-07
AM065529  phosphatidylinositol glycan 
anchor biosynthesis, class C
PIGC -1.87 0.00768685 C0000464i24 0.000932 0.0035645
AM066655  ring finger protein 213 RNF213 -1.88 0.01710267 C0000468o22 0.002701 0.00791854
AM065143
proteasome (prosome, 
macropain) subunit, alpha 
type, 5 
PSMA5 -1.88 0.03587341 C0000463h13 0.007323 0.01661205
AM067245 OGT OGT -1.89 0.00989919 C0000473m2
0
0.001302 0.00458954
AM071166  GNAS complex locus GNAS -1.90 0.00045267 C0000853i14 2.15E-05 0.00020959
AM066552  vacuolar protein sorting 4 
homolog A (S. cerevisiae)
VPS4A -1.94 7.08E-06 C0000468k04 8.93E-08 3.28E-06
AM066657 Meis homeobox 1 MEIS1 -1.94 0.00238733 C0000468o24 0.000196 0.00110691
AM064422 fra-2 gene FRA-2 -1.95 1.92E-05 C0000858n09 3.46E-07 8.90E-06
AM067515 LOC769729 LOC769729 -1.95 0.02763434 C0000474j19 0.005116 0.0127947
AM065649
 sulfotransferase family 1E, 
estrogen-preferring, member 
1
SULT1E1 -1.96 0.03246838 C0000464o10 0.006375 0.01504335
AM071048 UDP-glucose 6-
dehydrogenase
UGDH -1.97 0.00089409 C0000853c24 5.46E-05 0.00041427
AM069817  cathepsin C CTSC -1.98 5.41E-07 C0000878e05 2.44E-09 2.51E-07
AM069285
 Epidermal growth factor 
receptor pathway substrate 
15-like 1
EPS15L1 -1.99 5.61E-06 C0000874k01 6.72E-08 2.64E-06
AM068919 T cell receptor delta chain TCRd -1.99 0.00094994 C0000873j06 5.89E-05 0.00043982
AM066639 fucosyltransferase 11 (alpha 
(1,3) fucosyltransferase)
FUT11 -2.05 0.02997203 C0000468o03 0.005737 0.01387705
AM072142 phosphoinositide-3-kinase 
interacting protein 1
PIK3IP1 -2.06 0.00845818 CHK0200003
9n24
0.001058 0.00391614
AM068062  syntaxin binding protein 1 STXBP1 -2.10 0.00760767 C0000485c15 0.000914 0.00352235
AM070526 lymphocyte-specific protein 
1; LOC771119
LSP1 -2.11 0.04826822 C0001683C14 0.010801 0.02234819
AM067431  interferon, gamma-inducible 
protein 30
IFI30 -2.14 9.85E-08 C0000474g02 2.06E-10 4.56E-08
BU376898  fms-related tyrosine kinase FLT3 -2.15 0.01379543 603812446F1 0.002046 0.00638729
AM067301 LOC428714 LOC428714 -2.16 3.26E-07 C0000473p08 1.30E-09 1.51E-07
AM065666 fibronectin 1 FN1 -2.23 0.03565707 C0000464p04 0.007244 0.01650923
AM067298
ATPase, Na+/K+ 
transporting, beta 1 
polypeptide 
ATP1B1 -2.25 1.72E-09 C0000473p05 3.43E-13 7.94E-10
AM066648  cysteinyl leukotriene 
receptor 2
CYSLTR2 -2.38 0.04634595 C0000468o13 0.010316 0.02145817
AM071279 No blast file found -2.38 8.74E-09 C0000853o05 7.00E-12 4.05E-09
AM066046 aldehyde oxidase 1 AOX1 -2.44 0.02749861 C0000467b21 0.005075 0.01273733
AM064763  tripartite motif containing 47 TRIM47 -2.47 0.02085304 C0000360g03 0.003519 0.00965496
AM067256  complement factor D 
(adipsin)
CFD -2.48 0.02561786 C0000473n10 0.00462 0.01186472
AM066667
 mucosa associated 
lymphoid tissue lymphoma 
translocation gene 1
MALT1 -2.50 0.00061038 C0000468p11 3.09E-05 0.00028261
AM066091  tripartite motif containing 25 TRIM25 -2.61 0.00370029 C0000467d24 0.000345 0.00171323
AM065719  transmembrane protein 86A TMEM86A -2.62 2.41E-05 C0000465c03 4.87E-07 1.12E-05
AM075259  cathelicidin-B1-like CATHB1 -2.69 0.01364428 C0000222i17 0.002012 0.00631772





 KIAA1671 -3.05 0.02136954 C0000467k18 0.003653 0.0098941
AM063343  patatin-like phospholipase 
domain containing 3




 smg-1 homolog, 
phosphatidylinositol 3-kinase-
related kinase (C. elegans)
SMG1 -3.19 0.01490534 C0000360i04 0.002267 0.00690117
AM067376 coiled-coil domain containing 
50 
CCDC50 -3.22 0.01853476 C0000474d01 0.003007 0.00858932
AM070038 SATB homeobox 1 SATB1 -3.35 0.00079094 C0000878o24 4.53E-05 0.0003662
Mock comparisons over time
Genbank Gene name
Mock 48 h 
Vs 24 h
Mock 72 h Vs 
48 h
Mock 72 h Vs 
Mock 24 h
AM064840 prostaglandin D2 synthase 21kDa 
(brain) (PTGDS)
2.24 1.83 4.10
AM066552 SKD1-homolog (Vacuolar protein 
sorting factor 4A) 
1.49 2.41 3.59
AM067808 Transforming growth factor, beta-
induced, 68kDa
1.50 2.35 3.51
AM067484 TIA1 cytotoxic granule-associated 
binding proten
2.64 1.33 3.50
AM069981 TCR gamma alternate reading frame 2.73 1.17 3.18
AM069466 LOC100859882 1.38 2.31 3.17
AM066473 Mitochondrial ribosomal protein L38 
(MRPL38)
1.44 2.08 2.99
AM066667 mucosa-associated lymphoid tissue 
lymphoma translocation protein 1
1.35 2.20 2.98
AM065673 Polypyrimidine tract-binding protein 1, 
isoform a,
2.00 1.42 2.84
AM067821 WD repeat domain, phosphoinositide 
interacting 1 (WIPI1)
1.33 2.13 2.84
AM064974 fatty acid desaturase 6-like 1.94 1.45 2.80
AM066658 Sarcoglycan, beta (43kDa dystrophin-
associated glycoprotein) (SGCB)
1.33 2.09 2.77
AM071717 DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 17 (DDX17)
1.49 1.81 2.70
AM065873 Uncharacterised 1.21 2.21 2.68
AM066366
MID1 interacting protein 1 
(gastrulation specific G12 homolog 
(zebrafish)) (MID1IP1)
1.79 1.47 2.63
AM070038 SATB homeobox 1 (SATB1) 0.90 2.93 2.63
AM067431 Interferon, gamma-inducible protein 
30 (IFI30)
1.50 1.74 2.62
AM069080 Uncharacterised 1.46 1.77 2.60
AM063650 Uncharacterised 1.33 1.94 2.58
AM064797 DC12 protein 0.70 3.68 2.56
AM064925 GRB2-related adaptor protein 
(GRAP)
1.81 1.41 2.55
AM070212 6-phosphogluconolactonase 1.52 1.67 2.54
AM071638 Uncharacterised LOC417345 
(LOC417345)
1.34 1.86 2.50
AM068467 ChaC, cation transport regulator 
homolog 1 (E. coli) (CHAC1)
1.37 1.82 2.49
AM071923 Zinc finger protein 207 (ZNF207) 1.38 1.79 2.47
AM064561 MOB family member 4, phocein 
(MOB4)
1.27 1.94 2.47
AM065870 Uncharacterised 1.14 2.15 2.46
AM067686 Uncharacterised 1.96 1.25 2.46
AM066460 Mitogen-activated protein kinase 14 
(MAPK14)
1.15 2.12 2.44
AM067846 Uncharacterised 1.11 2.19 2.43
AM064738 CD3d molecule, delta (CD3-TCR 
complex) (CD3D)
1.81 1.33 2.41
AM066186 Ras association (RalGDS/AF-6) 
domain family member 2 (RASSF2)
1.73 1.36 2.35
AM072184 post-GPI attachment to proteins 
factor 2-like 
1.12 2.08 2.33
AM064440 Uncharacterised 1.31 1.77 2.32




Fucosyltransferase 11 (alpha (1,3) 
fucosyltransferase) (FUT11) 0.87 2.58 2.26
AM075540 Uncharacterised 1.14 1.98 2.25
AM066113 Cathepsin B (CTSB) 1.21 1.85 2.25
AM065752 Zinc finger CCCH-type containing 
11A (ZC3H11A)
1.38 1.63 2.25
AM070420 Uncharacterised 1.32 1.70 2.24
AM067296
Retinoic acid receptor responder 
(tazarotene induced) 1 (RARRES1) 1.31 1.72 2.24
AM063483
CCAAT/enhancer binding protein 
(C/EBP), gamma (CEBPG) 1.38 1.62 2.23




Polymeric immunoglobulin receptor 
(PIGR) 1.41 1.57 2.21
AM063666 Peroxisomal biogenesis factor 5 
(PEX5)
1.65 1.33 2.20
AM064497 Crystallin, mu (CRYM) 1.41 1.54 2.18
AM065876 Calponin 2 (CNN2) 1.16 1.87 2.16
AM071587 serine/threonine-protein kinase ULK2 1.33 1.62 2.16
AM063681 Uncharacterised 1.64 1.30 2.13
AM068079 PRELI domain containing 1 
(PRELID1)
0.98 2.17 2.13
BU271029 Interleukin 18 1.90 1.12 2.13
AM071706
Glutamate receptor, ionotropic, 
AMPA 1 (GRIA1) 1.41 1.50 2.12
AM064118
Runt-related transcription factor 1 
(RUNX1) 1.87 1.13 2.12
AM068845 Proline-rich nuclear receptor 
coactivator 1 (PNRC1)
1.12 1.89 2.11
AM069918 DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 17 (DDX17)
1.19 1.75 2.09
AM067418 Uncharacterised 1.44 1.45 2.08
AM075288 Uncharacterised 1.35 1.54 2.08
AM068831 Uncharacterised 1.23 1.68 2.07
AM068933 Esterase D (ESD) 1.39 1.49 2.07
AM067735 ankyrin repeat domain-containing 
protein 57
1.26 1.64 2.06
AM067786 Tumor protein p53 inducible nuclear 
protein 1 (TP53INP1)
1.15 1.78 2.06
AM068416 Uncharacterised LOC100857204 
(LOC100857204)
1.39 1.47 2.04
AM071530 Cyclin L1 (CCNL1) 1.14 1.79 2.04




ATPase, Na+/K+ transporting, beta 1 
polypeptide (ATP1B1) 1.43 1.42 2.03
AM066172 anaphase-promoting complex subunit 
2
1.20 1.68 2.03
AM064395 LOC100859882 (LOC100859882) 1.13 1.78 2.02
AM063908 Adenosine deaminase (ADA) 1.14 1.77 2.01
AM065717
Protein tyrosine phosphatase, 
receptor type, C (PTPRC) 1.55 1.30 2.01
AM075291 Uncharacterised 1.18 1.69 1.99
AM071166 Uncharacterised 1.23 1.62 1.99
AM068744
TruB pseudouridine (psi) synthase 
homolog 2 (E. coli) (TRUB2) 1.12 1.77 1.98
AM065683  Annexin A5 (Annexin V) 1.86 1.06 1.97
AM063054
DENN/MADD domain containing 5B 
(DENND5B) 1.37 1.42 1.95
AM069676
Eukaryotic translation elongation 
factor 1 beta 2 (EEF1B2) 1.26 1.54 1.94
AM071526 SID1 transmembrane family member 
2
1.37 1.42 1.94
AM067516 Uncharacterised 1.18 1.64 1.94
AM069278 CD247 molecule (CD247) 1.36 1.41 1.92
AM069010
Spermidine/spermine N1-
acetyltransferase 1 (SAT1) 1.17 1.64 1.91
AM067340 Prosaposin (PSAP) 1.17 1.63 1.91
AM068965
Eukaryotic translation initiation factor 
2, subunit 3 gamma, 52kDa (EIF2S3) 1.23 1.54 1.91
AM066091 E3 ubiquitin/ISG15 ligase TRIM25 0.97 1.97 1.91
AM069691 Uncharacterised 0.92 2.07 1.90
AM068455 ATPase, Ca++ transporting, 
ubiquitous (ATP2A3)
1.36 1.40 1.90
AM067739 Uncharacterised 1.20 1.57 1.89
AM071636
Phosphoglycolate phosphatase 
(PGP) 1.12 1.68 1.89
AM063982 T-cell receptor gamma Vg3-Jg3 1.93 0.97 1.88
AM067870 Uncharacterised 1.21 1.55 1.88




Phospholipase A2 receptor 1, 
180kDa (PLA2R1) 1.13 1.65 1.87
AM064422 Uncharacterised 0.88 2.12 1.86
AM069481
Coactosin-like 1 (Dictyostelium) 
(COTL1) 1.40 1.33 1.86
AM070773
Cytohesin 1 interacting protein 
(CYTIP) 1.78 1.04 1.86








AM067768 Ribosomal protein L10a (RPL10A) 1.40 1.31 1.83
AM066046 Aldehyde oxidase 1 (AOX1) 1.14 1.60 1.82
AM068004 Zinc finger protein 593 (ZNF593) 1.16 1.57 1.82
AM064852 Uncharacterised 1.66 1.09 1.81
AM070285
Ras homolog gene family, member A 
(RHOA) 1.26 1.43 1.81
AM065739
Solute carrier family 7 (amino acid 
transporter light chain, L system), 
member 5 (SLC7A5)
1.44 1.26 1.81
AM064361 Zinc finger protein 706 (ZNF706) 1.27 1.43 1.81
AM064828 protein lin-37 homolog 1.84 0.98 1.80
AM069118 Solute carrier family 38, member 2 
(SLC38A2)
1.15 1.56 1.79
AM065272 Arylformamidase (AFMID) 1.42 1.26 1.79
AM064675 Major vault protein (MVP) 1.45 1.23 1.78
AM070256 protein jagunal homolog 1 1.10 1.62 1.78
AM065546
Phosphodiesterase 4A, cAMP-




AM070666 Uncharacterised 0.96 1.84 1.77
AM071251 Dual specificity phosphatase 1 
(DUSP1)
1.33 1.32 1.75
AM067521 Uncharacterised 1.27 1.38 1.75
AM067602 Uncharacterised 1.11 1.58 1.75
AM067831 Uncharacterised 1.20 1.45 1.73
AM063268
Acidic (leucine-rich) nuclear 
phosphoprotein 32 family, member B 
(ANP32B)
1.23 1.40 1.73
AM071279 Uncharacterised 0.83 2.08 1.73
AM063331
Eukaryotic translation initiation factor 
3, subunit E (EIF3E) 1.19 1.45 1.72
BU240159
Single immunoglobulin and toll-
interleukin 1 receptor (TIR) domain 
(SIGIRR)
1.61 1.07 1.72




AM067243 Uncharacterised 1.54 1.11 1.71
AM066724
Proline-rich nuclear receptor 
coactivator 1 (PNRC1) 1.13 1.52 1.71
AM068035 Sequestosome 1 (SQSTM1) 0.85 2.00 1.70
AM071288
Chromosome 10 open reading frame, 
human C15orf48 (C10H15orf48) 1.20 1.42 1.70
AM064796  transmembrane protein 100-like 1.17 1.45 1.70
AM067617 keratin, type I cytoskeletal 20 1.14 1.48 1.69
AM071578  ERO1-like protein alpha isoform 3 1.15 1.46 1.69
AM069789 Vinculin (VCL) 1.41 1.19 1.69
AM069817 dipeptidyl peptidase 1 0.77 2.20 1.68




TNF receptor-associated factor 5 
(TRAF5) 1.29 1.30 1.68
AM068412 Jun proto-oncogene (JUN) 1.34 1.25 1.68
AM069913 Zinc finger protein 706 (ZNF706) 1.27 1.32 1.67
AM066098 Uncharacterised 1.82 0.91 1.67
AM067769
SEC13 homolog (S. cerevisiae) 
(SEC13) 0.93 1.77 1.66
AM064002 Uncharacterised 1.56 1.07 1.66
AM071022
Jumonji domain containing 1C 
(JMJD1C) 1.10 1.51 1.66
AM065842 dipeptidyl peptidase 2 1.38 1.19 1.65
AM065842 dipeptidyl peptidase 2 1.42 1.16 1.65
AM071762
Eukaryotic translation initiation factor 
3, subunit H (EIF3H) 1.20 1.37 1.65
AM066578 Uncharacterised 1.17 1.40 1.64
AM063372
Potassium channel tetramerisation 
domain containing 20 (KCTD20) 1.34 1.22 1.64
AM069072 Uncharacterised 1.13 1.44 1.64
AM065826 Uncharacterised 1.51 1.08 1.63
AM065136
Zinc finger, DHHC-type containing 13 
(ZDHHC13) 1.40 1.16 1.63
AM068667
CD3d molecule, delta (CD3-TCR 
complex) (CD3D) 1.46 1.11 1.63
BU438609 Interferon regulatory factor 2 (IRF2) 1.18 1.37 1.63
AM070880 Apolipoprotein A-I (APOA1) 1.70 0.96 1.63
AM063586
Osteoclast stimulating factor 1 
(OSTF1) 1.24 1.31 1.63
AM068208 Uncharacterised 1.19 1.36 1.62
AM064390 Uncharacterised 0.91 1.78 1.62
AM066517 Uncharacterised 1.42 1.14 1.62








AM071559 MHC BF2 class I (BF2) 1.08 1.49 1.61
AM067844 protein Mpv17-like 1.12 1.45 1.61
AM071665 Uncharacterised 1.21 1.33 1.61
AM071122 Myosin IF (MYO1F) 1.26 1.28 1.61
AM068671
Tumor protein, translationally-
controlled 1 (TPT1) 1.13 1.43 1.61
AM067792 Uncharacterised 0.82 1.97 1.61
AM075249 Uncharacterised 1.14 1.41 1.61
AM071076 Uncharacterised 1.11 1.44 1.60
AM067412 Uncharacterised 0.98 1.64 1.60
AM068492 Ring finger protein 185 (RNF185) 1.15 1.39 1.60
AM067504
Xylosylprotein beta 1,4-




Histocompatibility (minor) HA-1 
(HMHA1) 1.15 1.39 1.59
AM065878 tripeptidyl-peptidase 1 1.48 1.07 1.59
AM066756 Uncharacterised protein LOC769674 1.28 1.25 1.59
AM068040 Uncharacterised 0.83 1.92 1.58
AM063715
SEC22 vesicle trafficking protein 
homolog A (S. cerevisiae) (SEC22A) 1.20 1.31 1.58
AM066656 Uncharacterised 1.15 1.37 1.58
AM063705
Heterogeneous nuclear 
ribonucleoprotein D-like (HNRPDL) 1.24 1.27 1.57
AM070371 FK506-binding protein 15 1.08 1.45 1.57
AM069768
Purinergic receptor P2Y, G-protein 
coupled, 10 (P2RY10) 0.94 1.66 1.56
AM066227 Uncharacterised protein KIAA1671-
like
0.95 1.64 1.56
AM070394 Uncharacterised 1.23 1.27 1.56
AM063717 Protein kinase N2 (PKN2) 1.24 1.26 1.56
AM071765 Anti-apoptotic NR13 (NR13) 1.27 1.23 1.56
AM070838 collagen alpha-2(VI) chain precursor 1.12 1.39 1.56
AM067006 cyclin-dependent kinase 12 isoform 2 1.27 1.23 1.56
AM068944 regulator of G-protein signaling 1 1.31 1.19 1.56
AM066174 Death inducer-obliterator 1 (DIDO1) 1.28 1.21 1.55
AM067267 Neuron navigator 3 (NAV3) 1.26 1.22 1.55
AM066704
Eukaryotic translation initiation factor 
4B (EIF4B) 1.13 1.36 1.54
AM071319 Uncharacterised 0.98 1.58 1.54
AM075339 Uncharacterised 0.96 1.61 1.54
AM072147 MHC BF2 class I (BF2) 1.19 1.29 1.54
AM067791 Uncharacterised 1.15 1.34 1.54
AM067389
Der1-like domain family, member 3 
(DERL3) 1.15 1.34 1.54
AM067389
Der1-like domain family, member 3 
(DERL3) 1.21 1.26 1.53
AM067354
Deoxyribonuclease I-like 3 
(DNASE1L3) 1.31 1.17 1.53
AM064763 tripartite motif-containing protein 47-
like
0.72 2.13 1.53




Microtubule-actin crosslinking factor 1 
(MACF1) 1.20 1.28 1.53
AM065516 Noggin 2 (NOG2) 0.88 1.73 1.53
AM066706
Enhancer of mRNA decapping 3 
homolog (S. cerevisiae) (EDC3) 1.41 1.08 1.52
AM063277
Lysosomal-associated membrane 
protein 3 (LAMP3) 1.17 1.30 1.52
AM066790
Actin, gamma 2, smooth muscle, 
enteric (ACTG2) 1.31 1.17 1.52
AM066573
Polymerase (DNA directed), lambda 
(POLL) 1.40 1.09 1.52
AM071048
UDP-glucose 6-dehydrogenase 
(UGDH) 1.09 1.39 1.52
AM071914
Collagen, type XXV, alpha 1 
(COL25A1) 1.15 1.31 1.51
AM068792
Solute carrier family 2 (facilitated 




RAB11B, member RAS oncogene 
family (RAB11B) 1.45 1.04 1.51
AM067043 microtubule-actin cross-linking factor 
1 
1.11 1.37 1.51
AM067515 Uncharacterised protein LOC426064 0.86 1.75 1.51
BU114872
Interleukin 16 (lymphocyte 
chemoattractant factor) (IL16) 1.17 1.30 1.51
AM066525 F-box protein 9 (FBXO9) 1.12 1.35 1.51
AM069311
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 42 (DDX42) 1.16 1.29 1.51
AM066075
Influenza virus NS1A binding protein 
(IVNS1ABP) 1.50 0.58 0.88
AM065040 SAFB-like, transcription modulator 0.64 1.29 0.83
AM065320
Fasciculation and elongation protein 
zeta 1 (zygin I) (FEZ1) 1.23 0.60 0.73
AM065907 Archain 1 (ARCN1) 0.72 1.02 0.73
AM071045 Thymidylate synthetase (TYMS) 1.12 0.66 0.73
AM065310
C-type lectin domain family 2 
member D-like (LOC776458) 0.90 0.81 0.73
AM067164 Uracil-DNA glycosylase (UNG) 0.97 0.75 0.73
AM071267 bromodomain-containing protein 4 0.92 0.80 0.73
AM065950
Acidic (leucine-rich) nuclear 
phosphoprotein 32 family, member B 
(ANP32B)
0.91 0.81 0.73
AM071137 methylosome subunit pICln 0.95 0.77 0.73
AM068562 Prohibitin 2 (PHB2) 0.86 0.85 0.73
AM066395
Rac/Cdc42 guanine nucleotide 
exchange factor (GEF) 6 (ARHGEF6) 0.70 1.04 0.73
AM069631 Glutaredoxin 5 (GLRX5) 0.83 0.88 0.73
AM069631 Glutaredoxin 5 (GLRX5) 0.89 0.81 0.73
AM064388
N-acetylglucosamine-1-phosphate 




Smu-1 suppressor of mec-8 and unc-




AM068006 Uncharacterised 0.84 0.87 0.73
AM068462 Formin binding protein 4 (FNBP4) 0.78 0.93 0.73
AM072052
Acetyl-CoA acetyltransferase 2 
(ACAT2) 1.11 0.65 0.73
AM069527 Uncharacterised protein LOC428145 0.91 0.80 0.72
AM066881 Uncharacterised 0.93 0.78 0.72
AM068153 Uncharacterised 0.86 0.84 0.72
AM070267
Heterogeneous nuclear 
ribonucleoprotein D-like (HNRPDL) 1.12 0.64 0.72
AM069077 Uncharacterised 0.88 0.82 0.72
AM072006
Signal sequence receptor, beta 
(translocon-associated protein beta) 
(SSR2)
0.83 0.87 0.72
AM068821 Selenoprotein W, 1 (SEPW1) 0.93 0.77 0.72
AM065225 ubiquitin-like modifier-activating 
enzyme 1
0.86 0.84 0.72
AM065319 meprin A subunit beta-like 0.77 0.93 0.72
AM068041
Growth hormone inducible 
transmembrane protein (GHITM) 0.92 0.78 0.72
AM066140
Jumonji domain containing 1C 
(JMJD1C) 1.15 0.63 0.72
AM072175 GON-4-like protein 0.65 1.11 0.72
AM069999
Transmembrane protein 18 
(TMEM18) 0.82 0.88 0.72
AM070210 Stomatin (EPB72)-like 2 (STOML2) 0.87 0.83 0.72




Chromosome 5 open reading frame, 
human C15orf24 (C5H15orf24) 0.86 0.83 0.72
AM065840 U3 small nucleolar ribonucleoprotein 
protein IMP3
0.92 0.78 0.72




Vacuolar protein sorting 37 homolog 
B (S. cerevisiae) (VPS37B) 0.92 0.78 0.71
AM063250 transforming growth factor beta-2 0.88 0.81 0.71
AM072107
Eukaryotic translation initiation factor 
4A3 (EIF4A3) 0.90 0.79 0.71
AM067376
Coiled-coil domain containing 50 
(CCDC50) 1.44 0.49 0.71
AM066000 Ephrin-B1 (EFNB1) 0.91 0.78 0.71
AM063799 Tubulin, gamma 1 (TUBG1) 0.78 0.91 0.71
AM068139 zinc finger and BTB domain-
containing protein 26
0.98 0.73 0.71
AM064189 nuclear pore complex protein Nup214 0.96 0.73 0.71
AM067259
Phosphatidic acid phosphatase type 
2 domain containing 1B (PPAPDC1B) 0.79 0.89 0.71
AM070813 Sorting nexin 1 (SNX1) 0.86 0.82 0.71
AM069685 THO complex 5 (THOC5) 0.84 0.84 0.71
AM066456 DNA repair protein complementing 
XP-A cells homolog
1.21 0.58 0.71
AM068149 serine/threonine-protein kinase 
DCLK3
0.81 0.87 0.71
AM063046 histone H1.10 0.96 0.73 0.70
AM066472 F-box/LRR-repeat protein 5 isoform 1 0.83 0.84 0.70
AM070198 uroporphyrinogen decarboxylase 0.84 0.84 0.70
AM067522
Coiled-coil domain containing 90B 
(CCDC90B) 0.95 0.74 0.70
AM063600 Family with sequence similarity 136, 
member A (FAM136A)
0.87 0.80 0.70
AM075364 Uncharacterised 0.88 0.80 0.70
AM067578
Geminin, DNA replication inhibitor 
(GMNN) 0.93 0.76 0.70
AM071307 thioredoxin-like 4A isoform 2 0.81 0.86 0.70
AM063096
Translin-associated factor X (TSNAX)
0.85 0.82 0.70
AM066590 Uncharacterised 1.25 0.56 0.70
AM063707 Synaptojanin 2 (SYNJ2) 0.74 0.94 0.70
AM068536
Hematological and neurological 
expressed 1 (HN1) 0.87 0.80 0.70
AM069775
Chromosome 10 open reading frame, 
human C15orf42 (C10H15orf42) 1.15 0.60 0.70
AM068973 Peroxiredoxin 1 (PRDX1) 0.87 0.80 0.70
AM064068
NADH dehydrogenase (ubiquinone) 1 
alpha subcomplex, 12 (NDUFA12) 0.90 0.77 0.70
AM066004 cap-specific mRNA (nucleoside-2'-O-
)-methyltransferase 1-like
1.20 0.58 0.70




IMP (inosine 5'-monophosphate) 
dehydrogenase 2 (IMPDH2) 1.10 0.63 0.69
AM068034
Deoxythymidylate kinase (thymidylate 
kinase) (DTYMK) 1.11 0.63 0.69
AM070664 Uncharacterised 1.08 0.64 0.69
AM069760
ATP synthase, H+ transporting, 
mitochondrial F1 complex, gamma 
polypeptide 1 (ATP5C1)
0.97 0.71 0.69
AM066856 Uncharacterised 0.89 0.78 0.69
AM064054 Uncharacterised 0.86 0.81 0.69
AM063626 THO complex 4 (THOC4) 0.88 0.79 0.69
AM068111 Uncharacterised 0.91 0.76 0.69
AM070569 NAD synthetase 1 (NADSYN1) 0.94 0.73 0.69
AM071168
3-oxoacid CoA transferase 1 
(OXCT1) 1.15 0.60 0.69
AM065353 Uncharacterised 0.84 0.82 0.69
AM067375 ribonuclease kappa 0.88 0.77 0.68
AM068817 Uncharacterised 0.95 0.71 0.68
AM063270
Putative methyltransferase 
(LOC424014) 0.92 0.74 0.68
AM071148
Ubiquitin-conjugating enzyme E2F 
(putative) (UBE2F) 0.93 0.74 0.68
AM065728  sperm-associated antigen 5-lik 0.84 0.81 0.68
AM066474
Hydroxyacylglutathione hydrolase-
like (HAGHL) 0.95 0.71 0.68
AM069748
Polymerase (RNA) II (DNA directed) 
polypeptide H (POLR2H) 0.88 0.77 0.68




Microcephaly, primary autosomal 
recessive 1 (MCPH1) 0.80 0.85 0.68
AM068929 Dynactin 6 (DCTN6) 0.85 0.79 0.68
AM075531 Uncharacterised 0.86 0.79 0.68
AM063815 Centrin, EF-hand protein, 2 (CETN2) 0.96 0.70 0.67
AM066378 ras-related protein Rab-44-like 0.85 0.79 0.67
AM064149
GINS complex subunit 1 (Psf1 
homolog) (GINS1) 1.11 0.60 0.67
AM067379 Uncharacterised 0.92 0.73 0.67
AM066618 serine/threonine-protein kinase 
WNK4-like
0.94 0.71 0.67
AM072072 Ring finger protein 126 (RNF126) 0.79 0.85 0.67
AM066175 protein jagunal homolog 1 0.84 0.80 0.67
AM063956
Mitochondrial fission process 1 
(MTFP1) 0.93 0.72 0.67
AM066287
Cytoskeleton associated protein 2-
like (CKAP2L) 0.75 0.89 0.67




Cytochrome P450, family 8, 
subfamily B, polypeptide 1 (CYP8B1) 0.79 0.84 0.67
AM072011
Protease, serine, 2 (trypsin 2) 
(PRSS2) 0.92 0.72 0.66
AM063678
Polymerase (DNA directed), epsilon 3 
(p17 subunit) (POLE3) 0.86 0.77 0.66
AM067455
Crystallin, zeta (quinone reductase)-
like 1 (CRYZL1) 0.84 0.79 0.66
AM065574
phosphorylase b kinase regulatory 
subunit alpha, skeletal muscle 
isoform isoform 2
0.87 0.76 0.66
AM066182 Uncharacterised 0.77 0.86 0.66
AM070744
DnaJ (Hsp40) homolog, subfamily C, 
member 15 (DNAJC15) 0.91 0.72 0.66
AM066242 ADP-ribosylation factor-like 3 0.87 0.76 0.66
BU133519 EPH receptor A2 (EPHA2) 0.94 0.71 0.66
AM065714 protein jagunal homolog 1 0.77 0.86 0.66
AM064897 Uncharacterised 0.71 0.92 0.66
AM069890 DNA polymerase delta subunit 2-like 0.93 0.71 0.66
AM065606 MEF2B neighbor (MEF2BNB) 0.97 0.68 0.66
AM066530 Uncharacterised 0.86 0.76 0.66
AM070725 Uncharacterised 0.92 0.71 0.66
AM066655 Ring finger protein 213 (RNF213) 0.95 0.69 0.65
AM072086
Deleted in primary ciliary dyskinesia 
homolog (mouse) (DPCD) 0.79 0.83 0.65
AM064451
Ring finger and CHY zinc finger 
domain containing 1 (RCHY1) 0.86 0.76 0.65
AM067655 NADH dehydrogenase [ubiquinone] 1 
alpha subcomplex subunit 2
0.85 0.77 0.65
AM071949
B-cell antigen receptor complex-




Retinol saturase (all-trans-retinol 
13,14-reductase) (RETSAT) 0.89 0.73 0.65
AM064802 Uncharacterised 0.91 0.71 0.65
AM067040
Cytochrome P450, family 51, 
subfamily A, polypeptide 1 
(CYP51A1) 0.63 1.03 0.65
AM067495
Basic leucine zipper transcription 
factor, ATF-like (BATF) 0.91 0.71 0.65
AM068090 Uncharacterised 0.97 0.67 0.65
AM071198
Gem (nuclear organelle) associated 
protein 4 (GEMIN4) 0.72 0.90 0.65
AM071743
LSM5 homolog, U6 small nuclear 
RNA associated (S. cerevisiae) 
(LSM5)
0.81 0.81 0.65
AM070108 Brain protein 44-like (BRP44L) 0.89 0.73 0.65
AM075313 Uncharacterised 0.70 0.93 0.65




N(alpha)-acetyltransferase 50, NatE 
catalytic subunit (NAA50) 0.90 0.72 0.65
AM070757
Sec61 alpha 1 subunit (S. cerevisiae) 
(SEC61A1) 0.69 0.94 0.65
AM064217 Uncharacterised 0.76 0.85 0.65
AM065080
Deoxyribonuclease I-like 3 
(DNASE1L3) 0.98 0.66 0.65
AM064656 Uncharacterised 0.97 0.67 0.65
AM066116
Ubiquinol-cytochrome c reductase 
complex chaperone (UQCC) 0.76 0.84 0.65
AM064070
Tumor necrosis factor receptor 
superfamily, member 6b, decoy 
(TNFRSF6B)
0.98 0.66 0.65
AM071661 Adenosylhomocysteinase (AHCY) 0.94 0.69 0.64
AM066173
Peptidylprolyl isomerase E 
(cyclophilin E) (PPIE) 0.92 0.70 0.64
AM069849
Chemokine (C-X-C motif) receptor 4 
(CXCR4) 1.08 0.60 0.64
AM072185
Proteasome (prosome, macropain) 
26S subunit, non-ATPase, 1 
(PSMD1)
0.95 0.68 0.64
AM067352 germ cell-less protein-like 1 0.75 0.86 0.64
AM069783 Y box binding protein 1 (YBX1) 0.92 0.70 0.64
AM072004
Protein phosphatase 6, catalytic 
subunit (PPP6C) 0.83 0.77 0.64
AM066236
Uncharacterised LOC427029 
(LOC427029) 0.66 0.97 0.64
AM063541 nuclear pore complex protein Nup160 0.80 0.79 0.64
AM070331
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 17 (DDX17) 0.67 0.96 0.64
AM065955 Clathrin, light chain B (CLTB) 0.99 0.65 0.64
AM065175
Macrophage stimulating 1 




SWI/SNF related, matrix associated, 
actin dependent regulator of 
chromatin, subfamily e, member 1 
(SMARCE1)
0.70 0.91 0.64
AM071889 tubulin alpha-1B chain 0.85 0.74 0.64
AM069206
Heterogeneous nuclear 
ribonucleoprotein R (HNRNPR) 0.85 0.75 0.64
AM063499
ATP-binding cassette, sub-family F 
(GCN20), member 2 (ABCF2) 0.78 0.81 0.63
AM068109 Uncharacterised 0.83 0.76 0.63
AM070716 leucine-rich repeat-containing protein 
45
0.87 0.73 0.63
AM065819 probable phospholipid-transporting 
ATPase IG
0.76 0.83 0.63
AM063813 Uncharacterised 0.84 0.75 0.63
AM069568 Tubulin, beta 2C (TUBB2C) 0.90 0.70 0.63
AM069752
Acetyl-CoA acetyltransferase 1 
(ACAT1) 0.95 0.66 0.63
AM070145 microspherule protein 1 0.89 0.71 0.63
AM068858
Small nuclear ribonucleoprotein 
polypeptide B (SNRPB2) 0.73 0.85 0.63
AM070677
Pentatricopeptide repeat domain 3 
(PTCD3) 0.93 0.67 0.62
AM070849 TLC domain containing 1 (TLCD1) 0.83 0.75 0.62
AM067682
Replication protein A2, 32kDa 
(RPA2) 0.84 0.74 0.62
AM071776 nicotinamide riboside kinase 2-like 1.28 0.49 0.62
AM067475 Death associated protein 3 (DAP3) 0.81 0.77 0.62
AM066381
RAB19, member RAS oncogene 
family (RAB19) 0.85 0.73 0.62
AM066381
RAB19, member RAS oncogene 
family (RAB19) 0.91 0.68 0.62
AM071303
Solute carrier family 35, member B1 
(SLC35B1) 0.82 0.75 0.62
AM070333 Uncharacterised 0.91 0.68 0.62
AM070730 Death associated protein 3 (DAP3) 0.77 0.80 0.62
AM067405 cytosol aminopeptidase 0.77 0.80 0.61
AM069745 RAN binding protein 1 (RANBP1) 0.75 0.82 0.61
AM069745 RAN binding protein 1 (RANBP1) 0.85 0.72 0.61
AM066092
Misato homolog 1 (Drosophila) 
(MSTO1) 0.74 0.83 0.61
AM065676
DnaJ (Hsp40) homolog, subfamily C, 
member 17 (DNAJC17) 0.82 0.75 0.61
AM066591 Nipped-B homolog (NIPBL) 0.86 0.71 0.61
AM066178
TRNA splicing endonuclease 2 
homolog (S. cerevisiae) (TSEN2) 0.79 0.77 0.61
AM067711
Biphenyl hydrolase-like (serine 
hydrolase) (BPHL) 0.83 0.74 0.61
AM069665 Y box binding protein 1 (YBX1) 0.91 0.67 0.61
AM065862
Protein phosphatase 1, regulatory 
(inhibitor) subunit 8 (PPP1R8) 0.66 0.92 0.61
AM063783 Pyruvate kinase, muscle (PKM2) 0.82 0.74 0.61
AM066661
Chromatin accessibility complex 1 
(CHRAC1) 0.77 0.78 0.61




Adhesion regulating molecule 1 
(ADRM1) 0.86 0.70 0.61
AM064375
Lysine (K)-specific demethylase 5A 
(KDM5A) 1.20 0.51 0.61
AM066550 Kruppel-like factor 2 (lung) (KLF2) 0.73 0.83 0.61
AM070634
N(alpha)-acetyltransferase 40, NatD 





dioxygenase 2 (PLOD2) 0.78 0.77 0.60
AM067071 Uncharacterised 0.84 0.72 0.60
AM075355 Uncharacterised 0.85 0.71 0.60
AM071721 Uncharacterised 0.73 0.83 0.60
AM065999
Phosphoglycerate mutase 1 (brain) 
(PGAM1) 0.92 0.66 0.60
AM065085
BCL2-associated athanogene 2 
(BAG2) 0.82 0.74 0.60
AM071981 Lactate dehydrogenase B (LDHB) 0.79 0.77 0.60





(LOC426097) 0.90 0.67 0.60




ATPase, H+ transporting, lysosomal 
V0 subunit a1 (ATP6V0A1) 0.99 0.61 0.60
AM065200 Etoposide induced 2.4 mRNA (EI24) 0.66 0.91 0.60
AM064835 NF-kappa-B inhibitor epsilon-like 0.84 0.72 0.60
AM065009
Regulator of G-protein signaling 5 
(RGS5) 0.93 0.64 0.60
AM065525
Ras association (RalGDS/AF-6) 
domain family member 2 (RASSF2) 0.86 0.70 0.60
AM065171 RPE-spondin-like 0.67 0.90 0.60
AM066245
Proline synthetase co-transcribed 
homolog (bacterial) (PROSC) 0.81 0.73 0.60
AM071006 Acid phosphatase 1, soluble (ACP1) 0.96 0.62 0.60
AM071998 Cyclin Y-like 1 (CCNYL1) 0.90 0.66 0.60
AM066145
ADP-dependent glucokinase 
(ADPGK) 0.80 0.74 0.60
AM066108 Uncharacterised 0.96 0.62 0.60




ATP synthase, H+ transporting, 
mitochondrial F1 complex, alpha 
subunit 1, cardiac muscle (ATP5A1)
0.89 0.67 0.59
AM071077
Nudix (nucleoside diphosphate linked 




V-myb myeloblastosis viral oncogene 
homolog (avian) (MYB) 1.16 0.51 0.59
AM069217 Uncharacterised 0.78 0.76 0.59
AM066144
Golgi to ER traffic protein 4 homolog 
(S. cerevisiae) (GET4) 0.95 0.62 0.59
AM071894
SEC62 homolog (S. cerevisiae) 
(SEC62) 0.84 0.70 0.59
AM067421
Histidine triad nucleotide binding 
protein 1 (HINT1) 0.72 0.83 0.59
AM066025 Mitochondrial carrier 2 (MTCH2) 0.96 0.61 0.59
AM069127 Histidyl-tRNA synthetase (HARS) 0.71 0.83 0.59




Budding uninhibited by 




BRCA2 and CDKN1A interacting 
protein (BCCIP) 0.78 0.76 0.59
AM065330
Partner of NOB1 homolog (S. 
cerevisiae) (PNO1) 0.70 0.84 0.59
AM069303
Cysteine and glycine-rich protein 2 
(CSRP2) 0.96 0.61 0.59
AM069439
Proteasome (prosome, macropain) 




Proteasome (prosome, macropain) 
subunit, alpha type, 2 (PSMA2) 0.86 0.68 0.58
AM064832
Solute carrier family 19 (folate 
transporter), member 1 (SLC19A1) 0.74 0.78 0.58
AM065334 organic solute transporter subunit 
alpha-like
0.89 0.65 0.58
AM064298 proteasome subunit beta type-6 0.80 0.72 0.58
AM065940
Rho GTPase activating protein 19 
(ARHGAP19) 0.85 0.68 0.58
AM065755 Histone deacetylase 8 (HDAC8) 0.86 0.67 0.58
AM072094
Heat shock 70kDa protein 8 (HSPA8)
0.86 0.67 0.58
AM071236 39S ribosomal protein L2, 
mitochondrial 
0.84 0.68 0.57
AM068863 microspherule protein 1 0.84 0.68 0.57
AI982046 TNF RECEPTOR ASSOCIATED 
FACTOR 1 (TRAF1)
0.79 0.72 0.57
AM065351 Uncharacterised 0.95 0.60 0.57
AM075536 Uncharacterised 0.83 0.68 0.57
AM066159
dihydrolipoyllysine-residue 





Mitochondrial amidoxime reducing 
component 2 (MARC2) 0.87 0.64 0.56
AM069085
Eukaryotic translation initiation factor 
2B, subunit 2 beta, 39kDa (EIF2B2) 0.83 0.68 0.56
AM068150
Protein disulfide isomerase family A, 
member 6 (PDIA6) 0.73 0.76 0.56
AM065760 Patched 1 (PTCH1) 0.85 0.65 0.56
AM063986
Small nuclear ribonucleoprotein 
polypeptides B and B1 (SNRPB) 0.79 0.70 0.56
AM071781 Lectin, galactoside-binding, soluble, 3 
(LGALS3)
1.21 0.46 0.56
AM075570   Uncharacterised 0.82 0.68 0.56
AM063427 general transcription factor 3C 
polypeptide 2
0.93 0.60 0.55
AM067636 ubiquitin carboxyl-terminal hydrolase 
42
0.94 0.59 0.55
AM065891 cleavage and polyadenylation 
specificity factor subunit 5 
0.88 0.63 0.55
AM067023
Progressive external ophthalmoplegia 
1 (C6H10orf2) 0.78 0.70 0.55
AM064120 WD repeat domain 43 (WDR43) 0.74 0.75 0.55
AM069834
Replication factor C (activator 1) 2, 
40kDa (RFC2) 0.91 0.60 0.55
AM063936




AM067692 Uncharacterised 0.81 0.68 0.55
AM071794 Uncharacterised 0.88 0.62 0.55
AM065835
Structure specific recognition protein 
1 (SSRP1) 0.87 0.62 0.54
AM065886
N(alpha)-acetyltransferase 25, NatB 




AM066813 acyl-CoA synthetase family member 
2, mitochondrial 
0.82 0.66 0.54





domain containing 1 (QTRTD1) 0.87 0.62 0.54
AM064943 PROTEIN: receptor-type tyrosine-
protein kinase FLT3-like
0.78 0.69 0.54
AM065821 Protein kinase C, delta 0.51 1.05 0.54
AM075321 Uncharacterised 0.89 0.61 0.54




PRP38 pre-mRNA processing factor 
38 (yeast) domain containing A 
(PRPF38A)
0.88 0.61 0.54
AM065605 Uncharacterised 0.72 0.74 0.53
AM067207 Annexin A6 (ANXA6) 0.86 0.62 0.53
AM071803 Zinc finger, matrin type 5 (ZMAT5) 0.70 0.76 0.53







Vacuolar protein sorting 24 homolog 
(S. cerevisiae) (VPS24) 0.80 0.66 0.53
AM063729
Signal transducer and activator of 




Processing of precursor 5, 





box polypeptide 49 (DDX49)
-prov protein 
0.61 0.86 0.53
AM063749 CAD protein 0.89 0.59 0.52
AM066230 farnesyl pyrophosphate synthase 0.79 0.66 0.52
AM064023 WD repeat-containing protein 3 0.69 0.76 0.52
AM067047 Gephyrin (GPHN) 0.84 0.62 0.52
AM068974 SLAM family member 8-like 0.92 0.56 0.52
AM067991
Eukaryotic translation initiation factor 
2, subunit 1 alpha, 35kDa (EIF2S1) 0.89 0.58 0.52
AM065547 Uncharacterised 0.90 0.57 0.52
AM064711
RAB11A, member RAS oncogene 
family (RAB11A) 0.75 0.69 0.52
AM064079
Serine peptidase inhibitor, Kazal type 
5 (SPINK5) 0.70 0.74 0.52
AM064640 LOW QUALITY PROTEIN: GPI 
transamidase component PIG-T-like 
0.85 0.61 0.52




NADH dehydrogenase (ubiquinone) 1 
alpha subcomplex, 5, 13kDa 
(NDUFA5)
0.73 0.70 0.51
AM066313 Cystatin C (CST3) 0.77 0.66 0.51
AM070094 torsin-1B 0.70 0.72 0.51
AM069516
Phosphatidylethanolamine binding 
protein 1 (PEBP1) 0.73 0.69 0.51
AM066070 small subunit processome 
component 20 homolog 
0.85 0.60 0.51
AM064767
Family with sequence similarity 96, 
member A (FAM96A) 0.80 0.63 0.51
AM070410
Signal sequence receptor, alpha 
(SSR1) 0.75 0.67 0.50
AM067439
MAK16 homolog (S. cerevisiae) 
(MAK16) 0.77 0.65 0.50
AM066914 BTB/POZ domain-containing protein 
KCTD3
0.75 0.67 0.50




Mu immunoglobulin heavy chain C 
region 0.78 0.64 0.50
AM064653
Cytokine receptor-like factor 3 
(CRLF3) 0.78 0.63 0.50
AM065149
Mannosidase, alpha, class 1B, 
member 1 (MAN1B1) 0.78 0.63 0.49
AM068044
Peptidylprolyl isomerase B 
(cyclophilin B) (PPIB) 0.81 0.61 0.49
AM066719 FtsJ homolog 3 (E. coli) (FTSJ3) 0.65 0.76 0.49
AM071539 ADP-ribosylation factor-like 1 (ARL1) 0.77 0.63 0.49
AM065433 Uncharacterised 0.87 0.56 0.49
AM063885 Cyclin-dependent kinase 1 (CDK1) 0.92 0.53 0.49
AM070689 glutathione S-transferase omega-1 
isoform 2
0.76 0.64 0.49
AM064370 LYR motif containing 5 (LYRM5) 0.72 0.68 0.48
AM070721 tubulin alpha-1B chain 0.80 0.60 0.48
AM067279
LSM7 homolog, U6 small nuclear 
RNA associated (S. cerevisiae) 
(LSM7)
0.68 0.70 0.48
AM070678 peptidyl-prolyl cis-trans isomerase H 0.83 0.58 0.48
AM065852 Tropomodulin 1 (TMOD1) 0.62 0.77 0.47
AM063132 tubulin-folding cofactor B 0.73 0.64 0.47
AM068695 serine/arginine-rich splicing factor 2 0.88 0.54 0.47
AM068088 Uncharacterised 0.76 0.62 0.47
AM064344
Proliferating cell nuclear antigen 
(PCNA) 0.91 0.52 0.47
AM068994





AM065943 Dynein, light chain, Tctex-type 1 
(DYNLT1)
0.85 0.54 0.46
AM064778 Ribonucleotide reductase M1 (RRM1) 0.94 0.49 0.46
AM065324 Uncharacterised 0.81 0.56 0.46
AM065850
Ubiquitin specific peptidase 14 (tRNA-
guanine transglycosylase) (USP14) 0.70 0.65 0.45
AM069986
RAN, member RAS oncogene family 
(RAN) 0.74 0.61 0.45
AM071746 Thymosin beta 15 (LOC100502566) 0.79 0.57 0.45
AM068181 tubulin alpha-4A chain 0.70 0.64 0.45




Isoamyl acetate-hydrolyzing esterase 
1 homolog (S. cerevisiae) (IAH1) 0.59 0.75 0.45
AM066478 Leucine rich repeat and sterile alpha 
motif containing 1 (LRSAM1)
0.73 0.59 0.43
AM067252 Uncharacterised 0.78 0.54 0.42
AM063638 thimet oligopeptidase-like 0.66 0.64 0.42
AM065980 thimet oligopeptidase-like 0.75 0.55 0.41
AM070961 SLAM family member 8-like 1.08 0.38 0.41
AM069279 Heat shock 70kDa protein 8 (HSPA8) 0.77 0.53 0.40
AM063229 Heat shock 70kDa protein 8 (HSPA8) 0.64 0.62 0.40
AM065982
Solute carrier family 28 (sodium-
coupled nucleoside transporter), 
member 2 (SLC28A2)
0.77 0.51 0.40
AM072018 MHC class II beta chain (BLB2) 0.85 0.46 0.39
AM069616
Nuclear distribution gene C homolog 
(A. nidulans) (NUDC) 0.63 0.61 0.39
AM066709
Proteasome (prosome, macropain) 
26S subunit, non-ATPase, 3 
(PSMD3)
0.70 0.55 0.39
AM068108 Uncharacterised 0.31 1.23 0.38
AM066237 Chaperonin containing TCP1, subunit 
4 (delta)
0.73 0.50 0.37
AM071140 Small nuclear ribonucleoprotein 
polypeptide E (snRNP-E)
0.80 0.45 0.36
AM069195 Heat shock protein 70kDa beta 
protein 8
0.63 0.54 0.34
AM068465 nucleophosmin/nucleoplasmin 3 0.62 0.48 0.29
AM064397 Heat shock protein 90kDa beta 
(Grp94), member 1
0.49 0.59 0.29
Overlapped genes at 48 and 72 h
Genbank Name Gene symbol FoldChange 48 h
Fold Change 
72 h
AM071288 PREDICTED: normal mucosa of esophagus-specific gene 1 protein-like isoform 1 NMES1 2.11 -1.59
AM069035 protein FAM60A FAM60A 1.87 -1.56
AM063713 nuclear casein kinase and cyclin-dependent kinase substrate 1 (NUCKS1, JC7, NUCKS) NUCKS1 1.82 1.82
AM075540 No blast file found 1.81 -1.64
AM067693  death effector domain containing  DEDD 1.67 1.55
AM067846 Glyceraldehyde 3-phosphate dehydrogenase GAPDH 1.61 -1.56
AM071638 LOC417345 LOC417345 1.54 -1.51
AM069195 heat shock 70kDa protein 8 (HSPA8, HSC70) HSPA8 1.50 2.19
AM065739 solute carrier family 7 (amino acid transporter light chain, L system), member 5 SLC7A5 -1.55 -1.76
AM072025 YTH domain containing 1 YTHDC1 -1.58 -1.58
AM066657 Meis homeobox 1 MEIS1 -1.70 -1.94
AM069042  high mobility group protein HMGI-C-like HMGI-C -1.78 -1.66
AM068392 uncharacterized LOC107052719, transcript variant X1 LOC107052719 -1.81 -1.68
AM065719  transmembrane protein 86A TMEM86A -1.91 -2.62
AM066521  sulfotransferase family cytosolic 2B member 1-like SULT2B1 -2.10 -1.81
AM066655  ring finger protein 213 RNF213 -2.53 -1.88
AM067376 coiled-coil domain containing 50 CCDC50 -4.02 -3.22
AM070526 lymphocyte-specific protein 1 LSP1 -4.73 -2.11
Ingenuity Pathway analysis
Biological function analysis (48 h)
Category Time  P. Value Transcripts Transcripts




















Molecular Transport 48h 2.84E-04-4.91E-02 IFRD1,AP4B1,APOA1,PTGS1,PPBP,SLC7A5,L
Y6E,VAV1,GRIK2,ATP11B
10
Small Molecule Biochemistry 48h 2.84E-04-4.77E-02
IFRD1,FDPS,APOA1,PPBP,PTGS1,COL2A1 
(includes EG:1280),LY6E,SLC7A5,ATP11B 9
Inflammatory Disease 48h 6.49E-04-4.6E-02 FDPS,TRAK2,CNN3,APOA1,PTGS1,COL2A1 
(includes EG:1280),LY6E,CARD11
8
Tissue Morphology 48h 4.74E-03-4.6E-02 TGFBI,APOA1,PTGS1,COL2A1 (includes 
EG:1280),VAV1,ABCC10,CARD11,NID1
8





Embryonic Development 48h 7.8E-04-4.77E-02 IFRD1,APOA1,PTGS1,COL2A1 (includes 
EG:1280),LY6E,VAV1,NID1
7
Cell Signaling 48h 5.41E-03-3.03E-02 APOA1,PTGS1,CXXC5,PPBP,VAV1,GRIK2,CA
RD11
7
Inflammatory Response 48h 2.43E-04-4.77E-02 APOA1,PTGS1,PPBP,COL2A1 (includes 
EG:1280),VAV1,GRIK2,CARD11
7
Hereditary Disorder 48h 1.81E-03-4.6E-02 FLOT2,TGFBI,APOA1,PTGS1,PPBP,COL2A1 
(includes EG:1280),GRIK2
7
Infectious Disease 48h 5.88E-04-4.4E-02 FDPS,FLOT2,PPBP,PTGS1,VAV1,RRAGD 6
Developmental Disorder 48h 1.81E-03-4.94E-02 FDPS,FLOT2,TGFBI,APOA1,PTGS1,COL2A1 
(includes EG:1280)
6
Lipid Metabolism 48h 1.81E-03-4.77E-02 IFRD1,FDPS,APOA1,PPBP,PTGS1,ATP11B 6
Cardiovascular System Development 
and Function
48h 1.81E-03-4.6E-02 TGFBI,APOA1,PPBP,PTGS1,VAV1,NID1 6
Cellular Function and Maintenance 48h 1.81E-03-4.08E-02 APOA1,PTGS1,PPBP,VAV1,GRIK2,CARD11 6
Cell Death 48h 1.81E-03-3.21E-02 PPBP,PTGS1,VAV1,ABCC10,GRIK2,CARD11 6
Organ Development 48h 7.8E-04-4.77E-02 IFRD1,APOA1,COL2A1 (includes 
EG:1280),LY6E,NID1
5
Dermatological Diseases and 
Conditions
48h 5.41E-03-4.08E-02 CNN3,APOA1,PTGS1,COL2A1 (includes 
EG:1280),CARD11
5
Cell Morphology 48h 5.3E-04-4.6E-02 IFRD1,PTBP1,TGFBI,VAV1,CARD11 5
Hematological Disease 48h 3.61E-03-3.56E-02 FDPS,APOA1,PTGS1,VAV1,GRIK2 5
Cellular Development 48h 2.72E-03-4.6E-02 IFRD1,APOA1,PTGS1,VAV1,CARD11 5
Lymphoid Tissue Structure and 
Development
48h 2.72E-03-4.08E-02 TGFBI,PTGS1,ABCC10,VAV1,CARD11 5
Ophthalmic Disease 48h 1.81E-03-4.94E-02 TGFBI,APOA1,PTGS1,PPBP,COL2A1 
(includes EG:1280)
5
Metabolic Disease 48h 1.81E-03-4.6E-02 FDPS,FLOT2,TGFBI,APOA1,PTGS1 5
Cellular Growth and Proliferation 48h 1.81E-03-4.08E-02 APOA1,PPBP,VAV1,RCHY1,CARD11 5
Respiratory System Development and 
Function
48h 1.81E-03-3.61E-03 PTGS1,COL2A1 (includes EG:1280) 5
Cellular Assembly and Organization 48h 1.81E-03-3.38E-02 TRAK2,PTBP1,APOA1,COL2A1 (includes 
EG:1280),VAV1
5
Respiratory Disease 48h 1.81E-03-3.21E-02 FLOT2,TGFBI,PTGS1,COL2A1 (includes 
EG:1280),RRAGD
5
Psychological Disorders 48h 1.4E-02-4.43E-02 FDPS,APOA1,PPBP,GRIK2,NID1 5
Gastrointestinal Disease 48h 5.41E-03-4.94E-02 APOA1,PPBP,PTGS1,COL2A1 (includes 
EG:1280)
4
Renal and Urological Disease 48h 5.41E-03-3.56E-02 FDPS,APOA1,PTGS1,COL2A1 (includes 
EG:1280)
4
Hematopoiesis 48h 5.3E-04-4.6E-02 APOA1,PTGS1,VAV1,CARD11 4
Organismal Functions 48h 4.71E-03-1.79E-02 PPBP,PTGS1,COL2A1 (includes 
EG:1280),GRIK2
4
Vitamin and Mineral Metabolism 48h 3.61E-03-3.9E-02 FDPS,APOA1,PPBP,VAV1 4
Drug Metabolism 48h 2.84E-04-4.08E-02 PTGS1,SLC7A5,LY6E,CARD11 4
Antigen Presentation 48h 2.43E-04-4.77E-02 APOA1,PPBP,VAV1,CARD11 4
Skeletal and Muscular System 
Development and Function
48h 1.81E-03-4.77E-02 IFRD1,COL2A1 (includes 
EG:1280),LY6E,VGLL1
4
Cellular Compromise 48h 1.81E-03-4.6E-02 TGFBI,PPBP,SLC7A5,VAV1 4
Cardiovascular Disease 48h 1.81E-03-4.43E-02 APOA1,PTGS1,COL2A1 (includes 
EG:1280),GRIK2
4
Cellular Movement 48h 1.08E-02-4.06E-02 TGFBI,APOA1,PPBP,COL2A1 (includes 
EG:1280)
4
Cell Cycle 48h 7.21E-03-4.77E-02 TGFBI,VAV1,RCHY1 3
Endocrine System Disorders 48h 7.21E-03-4.01E-02 APOA1,CXXC5,PTGS1 3
Organismal Injury and Abnormalities 48h 5.41E-03-4.94E-02 APOA1,PTGS1,COL2A1 (includes EG:1280) 3
Connective Tissue Development and 
Function
48h 5.41E-03-4.77E-02 TGFBI,PPBP,COL2A1 (includes EG:1280) 3
Immune Cell Trafficking 48h 2.69E-04-3.73E-02 APOA1,PPBP,VAV1 3
Nervous System Development and 
Function
48h 1.81E-03-4.94E-02 IFRD1,COL2A1 (includes EG:1280),GRIK2 3
Cell-mediated Immune Response 48h 1.81E-03-4.08E-02 PTGS1,VAV1,CARD11 3
Protein Synthesis 48h 9.37E-03-3.73E-02 VAV1,CARD11 2
Tumor Morphology 48h 9.01E-03-3.21E-02 TGFBI,VAV1 2
Endocrine System Development and 
Function
48h 7.8E-04-3.9E-02 APOA1,LY6E 2
Digestive System Development and 
Function
48h 5.41E-03-5.41E-03 IFRD1,PTGS1 2
Hepatic System Disease 48h 5.41E-03-5.41E-03 APOA1,PTGS1 2
Reproductive System Development 
and Function
48h 5.41E-03-4.43E-02 PTGS1,SLC7A5 2
Reproductive System Disease 48h 5.41E-03-4.01E-02 CXXC5,PTGS1 2
Free Radical Scavenging 48h 3.61E-03-4.6E-02 PPBP,PTGS1 2
Energy Production 48h 3.61E-03-4.3E-02 APOA1,PTGS1 2
Post-Translational Modification 48h 3.56E-02-4.25E-02 TRAK2,RCHY1 2
Visual System Development and 
Function
48h 3.25E-03-4.43E-02 TGFBI,COL2A1 (includes EG:1280),NID1 2
RNA Post-Transcriptional 
Modification
48h 2.67E-02-2.67E-02 PTBP1,HNRNPA0 2
Cellular Response to Therapeutics 48h 2.46E-02-2.46E-02 PTGS1,RCHY1 2
Humoral Immune Response 48h 2.43E-04-4.43E-02 VAV1,CARD11 2
Carbohydrate Metabolism 48h 1.81E-03-4.77E-02 APOA1,COL2A1 (includes EG:1280) 2
Renal and Urological System 
Development and Function
48h 1.08E-02-3.73E-02 PTGS1,NID1 2
Dental Disease 48h 5.41E-03-5.41E-03 COL2A1 (includes EG:1280) 1
Hepatic System Development and 
Function
48h 5.41E-03-5.41E-03 PTGS1 1
Gene Expression 48h 3.61E-03-3.61E-03 VAV1 1
DNA Replication, Recombination, and 
Repair
48h 3.38E-02-3.38E-02 TGFBI 1
Hair and Skin Development and 
Function
48h 2.5E-02-2.5E-02 TGFBI 1
Amino Acid Metabolism 48h 1.81E-03-2.15E-02 SLC7A5 1
Ingenuity Pathway analysis
Biological function analysis (72 h)
Category Time  P.Value Transcripts Transcripts

















































































































































































































































































































































































































72h 5.72E-03-1.9E-02 CTSD,UGDH,ANXA5,NAGLU,STAT3,MVP 6
Gene 
Expression







72h 5.72E-03-7.53E-03 PCNA,FEN1,XPA,UNG 4
Organismal 
Functions
72h 2.17E-03-5.72E-03 ITGB2,GRIA1,NAGLU,TK1 4
Vitamin and 
Mineral 
72h 1.25E-03-1.25E-03 HSPA8,ACAT2,INSIG1,LSS 4
Protein Folding 72h 7.54E-03-7.54E-03 HSPA8,CCT4,BAG2 3
Hair and Skin 
Development 
72h 3.21E-04-1.14E-02 TP53INP1,STAT3,AKAP9 3
RNA 
Trafficking
72h 2.93E-03-1.8E-02 RAN,NUP214,HHEX 3
Skeletal and 
Muscular 
72h 1.04E-02-1.14E-02 PTPRC,ITGB2,LGALS3 3
Auditory and 
Vestibular 
72h 6.95E-03-1.71E-02 INSIG1,NAGLU 2
Drug 
Metabolism
72h 5.72E-03-1.14E-02 MVP,UNG 2
Hypersensitivit
y Response
72h 2.06E-03-1.11E-02 ITGB2,LGALS3 2
Humoral 
Immune 
72h 1.14E-02-1.71E-02 PTPRC,ITGB2 2
Endocrine 
System 
72h 5.72E-03-5.72E-03 HHEX 1
Ophthalmic 
Disease
72h 5.72E-03-5.72E-03 CST3 1
Energy 
Production
72h 5.72E-03-5.72E-03 UGDH 1
Respiratory 
System 
72h 1.14E-02-1.14E-02 ADA 1
Ingenuity Pathway analysis
Canonical pathway analysis (48 h)
Ingenuity Canonical Pathways Time  -log(p-value) Ratio Transcripts Transcripts
CD28 Signaling in T Helper Cells 48h 1.7 0.0152 VAV1,CARD11 2
PKCθ Signaling in T Lymphocytes 48h 1.71 0.0141 VAV1,CARD11 2
T Cell Receptor Signaling 48h 1.84 0.0183 VAV1,CARD11 2
Regulation of IL-2 Expression in 
Activated and Anergic T Lymphocytes
48h 2.03 0.0225 VAV1,CARD11 2
Protein Kinase A Signaling 48h 0.35 0.00299 GRK7 1
Actin Cytoskeleton Signaling 48h 0.481 0.00415 VAV1 1
LPS/IL-1 Mediated Inhibition of RXR 
Function
48h 0.485 0.00424 ALAS1 1
Leukocyte Extravasation Signaling 48h 0.523 0.00503 VAV1 1
Clathrin-mediated Endocytosis 
Signaling
48h 0.54 0.00513 APOA1 1
Production of Nitric Oxide and Reactive 
Oxygen Species in Macrophages 48h 0.542 0.00476 APOA1 1
Endothelin-1 Signaling 48h 0.552 0.00541 PTGS1 1





CREB Signaling in Neurons 48h 0.556 0.00498 GRIK2 1
PPARα/RXRα Activation 48h 0.564 0.00535 APOA1 1
Acute Phase Response Signaling 48h 0.58 0.00565 APOA1 1
Arachidonic Acid Metabolism 48h 0.582 0.00485 PTGS1 1
NF-κB Signaling 48h 0.582 0.00571 CARD11 1
Cdc42 Signaling 48h 0.591 0.00562 VAV1 1
B Cell Receptor Signaling 48h 0.625 0.00641 VAV1 1
IL-12 Signaling and Production in 
Macrophages
48h 0.657 0.00645 APOA1 1
PI3K Signaling in B Lymphocytes 48h 0.66 0.00699 VAV1 1
Ovarian Cancer Signaling 48h 0.665 0.00704 PTGS1 1
LXR/RXR Activation 48h 0.689 0.00735 APOA1 1
Gα12/13 Signaling 48h 0.712 0.00787 VAV1 1
Glycine, Serine and Threonine 
Metabolism
48h 0.721 0.00676 ALAS1 1
iCOS-iCOSL Signaling in T Helper 
Cells
48h 0.739 0.0082 VAV1 1
Amyotrophic Lateral Sclerosis 
Signaling
48h 0.742 0.00833 GRIK2 1
Fc Epsilon RI Signaling 48h 0.746 0.00901 VAV1 1
Natural Killer Cell Signaling 48h 0.753 0.00917 VAV1 1
Fcγ Receptor-mediated Phagocytosis 
in Macrophages and Monocytes
48h 0.788 0.0098 VAV1 1
FXR/RXR Activation 48h 0.796 0.0099 APOA1 1
Eicosanoid Signaling 48h 0.885 0.0127 PTGS1 1
Caveolar-mediated Endocytosis 
Signaling
48h 0.89 0.0118 FLOT2 1
Ephrin B Signaling 48h 0.896 0.0125 VAV1 1
PXR/RXR Activation 48h 0.912 0.0114 ALAS1 1
Glutamate Receptor Signaling 48h 0.96 0.0145 GRIK2 1
Biosynthesis of Steroids 48h 0.98 0.008 FDPS 1
Pentose Phosphate Pathway 48h 1.02 0.0125 DERA 1
Ephrin A Signaling 48h 1.06 0.0192 VAV1 1
Intrinsic Prothrombin Activation 





Role of Lipids/Lipid Rafts in the 
Pathogenesis of Influenza
48h 1.34 0.0357 FDPS 1
Ingenuity Pathway analysis




value) Ratio Transcripts Transcripts
Purine Metabolism 72h 1.84 0.0149 IMPDH2,ATP1B1,RNF213,R
RM2,ADA,RRM1
6





72h 1.73 0.017 HSPA8,CD247,KRAS,STAT3
,CD3D
5
Pyrimidine Metabolism 72h 2.37 0.0233 RRM2,DTYMK,UNG,TK1,RR
M1
5
Protein Ubiquitination Pathway 72h 1.21 0.0149 HSPA8,PSMA3,PSMA5,PSM
D3
4
PKCθ Signaling in T 
Lymphocytes
72h 2.31 0.0282 CD247,KRAS,CD3D,MAP3K
3
4
T Cell Receptor Signaling 72h 2.55 0.0367 PTPRC,CD247,KRAS,CD3D 4
Primary Immunodeficiency 
Signaling
72h 3.62 0.0635 PTPRC,ADA,CD3D,UNG 4
G-Protein Coupled Receptor 
Signaling
72h 0.243 0.0057 P2RY10,KRAS,STAT3 3
Xenobiotic Metabolism 
Signaling
72h 0.653 0.0102 KRAS,Sult1d1,MAP3K3 3
Phospholipase C Signaling 72h 0.803 0.0115 CD247,KRAS,CD3D 3
Huntington's Disease Signaling 72h 0.871 0.0127 HSPA8,CTSD,CAPN2 3
Actin Cytoskeleton Signaling 72h 0.879 0.0124 KRAS,LIMK2,ACTG2 3
Breast Cancer Regulation by 
Stathmin1
72h 0.98 0.0144 KRAS,LIMK2,CDK1 3
EIF2 Signaling 72h 1.03 0.0149 KRAS,EIF2S1,RPL10A 3
Clathrin-mediated Endocytosis 
Signaling
72h 1.04 0.0154 HSPA8,ITGB2,ACTG2 3
IL-8 Signaling 72h 1.04 0.0148 ITGB2,KRAS,LIMK2 3
Sertoli Cell-Sertoli Cell Junction 
Signaling
72h 1.04 0.0152 KRAS,ACTG2,MAP3K3 3
NRF2-mediated Oxidative 
Stress Response
72h 1.08 0.0157 CCT7,KRAS,ACTG2 3
Role of NFAT in Regulation of 
the Immune Response
72h 1.09 0.0152 CD247,KRAS,CD3D 3
Ephrin Receptor Signaling 72h 1.1 0.0151 KRAS,LIMK2,STAT3 3
Cdc42 Signaling 72h 1.17 0.0169 CD247,LIMK2,CD3D 3
B Cell Receptor Signaling 72h 1.27 0.0192 PTPRC,KRAS,MAP3K3 3
CD28 Signaling in T Helper 
Cells
72h 1.49 0.0227 PTPRC,CD247,CD3D 3
iCOS-iCOSL Signaling in T 
Helper Cells
72h 1.59 0.0246 PTPRC,CD247,CD3D 3
Type I Diabetes Mellitus 
Signaling
72h 1.6 0.0248 CD247,IFNGR2,CD3D 3
HGF Signaling 72h 1.68 0.0286 KRAS,STAT3,MAP3K3 3
Paxillin Signaling 72h 1.69 0.0268 ITGB2,KRAS,ACTG2 3
Virus Entry via Endocytic 
Pathways
72h 1.75 0.03 ITGB2,KRAS,ACTG2 3
VEGF Signaling 72h 1.79 0.0303 KRAS,ACTG2,EIF2S1 3
FAK Signaling 72h 1.83 0.0294 KRAS,CAPN2,ACTG2 3
Apoptosis Signaling 72h 1.84 0.0312 KRAS,CAPN2,CDK1 3
Regulation of IL-2 Expression in 
Activated and Anergic T 
Lymphocytes
72h 1.95 0.0337 CD247,KRAS,CD3D 3
Agrin Interactions at 
Neuromuscular Junction
72h 2.14 0.0435 ITGB2,KRAS,ACTG2 3
Calcium-induced T Lymphocyte 
Apoptosis
72h 2.19 0.0429 CD247,CAPN2,CD3D 3
Nur77 Signaling in T 
Lymphocytes
72h 2.39 0.0476 CD247,CD3D,MAP3K3 3
Role of Macrophages, 
Fibroblasts and Endothelial 
Cells in Rheumatoid Arthritis
72h 0.275 0.00599 KRAS,STAT3 2
Colorectal Cancer Metastasis 
Signaling
72h 0.391 0.00778 KRAS,STAT3 2
Signaling by Rho Family 
GTPases
72h 0.416 0.00791 LIMK2,ACTG2 2
Cardiac Hypertrophy Signaling 72h 0.418 0.0082 KRAS,MAP3K3 2
cAMP-mediated signaling 72h 0.452 0.00913 STAT3,AKAP9 2
Leukocyte Extravasation 
Signaling
72h 0.51 0.0101 ITGB2,ACTG2 2
ERK/MAPK Signaling 72h 0.534 0.0098 KRAS,STAT3 2
ILK Signaling 72h 0.537 0.0104 ITGB2,ACTG2 2
Production of Nitric Oxide and 
Reactive Oxygen Species in 
Macrophages
72h 0.54 0.00952 IFNGR2,MAP3K3 2
RhoGDI Signaling 72h 0.56 0.0101 LIMK2,ACTG2 2
CREB Signaling in Neurons 72h 0.563 0.00995 GRIA1,KRAS 2
Gap Junction Signaling 72h 0.581 0.011 KRAS,ACTG2 2
Inositol Phosphate Metabolism 72h 0.584 0.0101 LIMK2,CDK1 2
Acute Phase Response 
Signaling
72h 0.602 0.0113 KRAS,STAT3 2
NF-κB Signaling 72h 0.606 0.0114 KRAS,MAP3K3 2
Aldosterone Signaling in 
Epithelial Cells
72h 0.606 0.0116 HSPA8,KRAS 2
Regulation of eIF4 and p70S6K 
Signaling
72h 0.669 0.0115 KRAS,EIF2S1 2
Synaptic Long Term 
Depression
72h 0.733 0.0135 GRIA1,KRAS 2
PI3K Signaling in B 
Lymphocytes
72h 0.738 0.014 PTPRC,KRAS 2
GNRH Signaling 72h 0.768 0.0137 KRAS,MAP3K3 2
Nicotinate and Nicotinamide 
Metabolism
72h 0.817 0.0145 LIMK2,CDK1 2
CCR3 Signaling in Eosinophils 72h 0.828 0.0159 KRAS,LIMK2 2
Renin-Angiotensin Signaling 72h 0.834 0.0159 KRAS,STAT3 2
Hereditary Breast Cancer 
Signaling
72h 0.84 0.0157 KRAS,CDK1 2
IL-6 Signaling 72h 0.846 0.0161 KRAS,STAT3 2
RhoA Signaling 72h 0.864 0.0175 LIMK2,ACTG2 2
Synaptic Long Term 
Potentiation
72h 0.87 0.0175 GRIA1,KRAS 2
Role of Tissue Factor in Cancer 72h 0.877 0.0175 KRAS,LIMK2 2
Amyotrophic Lateral Sclerosis 
Signaling
72h 0.883 0.0167 GRIA1,CAPN2 2
NGF Signaling 72h 0.883 0.0172 KRAS,MAP3K3 2
Role of NANOG in Mammalian 
Embryonic Stem Cell 
Pluripotency
72h 0.889 0.0175 KRAS,STAT3 2
Pancreatic Adenocarcinoma 
Signaling
72h 0.896 0.0168 KRAS,STAT3 2
Natural Killer Cell Signaling 72h 0.902 0.0183 CD247,KRAS 2
Rac Signaling 72h 0.909 0.0164 KRAS,LIMK2 2
IGF-1 Signaling 72h 0.951 0.0189 KRAS,STAT3 2
Mouse Embryonic Stem Cell 
Pluripotency
72h 0.988 0.0202 KRAS,STAT3 2
SAPK/JNK Signaling 72h 0.988 0.0196 KRAS,MAP3K3 2
HMGB1 Signaling 72h 0.995 0.02 IFNGR2,KRAS 2
p53 Signaling 72h 1 0.0208 PCNA,TP53INP1 2
CTLA4 Signaling in Cytotoxic T 
Lymphocytes
72h 1.01 0.0204 CD247,CD3D 2
PAK Signaling 72h 1.02 0.0187 KRAS,LIMK2 2
Pyruvate Metabolism 72h 1.03 0.0144 ACAT2,HAGHL 2
OX40 Signaling Pathway 72h 1.07 0.0213 CD247,CD3D 2
Ceramide Signaling 72h 1.09 0.0227 CTSD,KRAS 2
Lysine Degradation 72h 1.1 0.0146 ACAT2,DLST 2
Cytotoxic T Lymphocyte-
mediated Apoptosis of Target 
Cells
72h 1.11 0.0235 CD247,CD3D 2
Acute Myeloid Leukemia 
Signaling
72h 1.14 0.0244 KRAS,STAT3 2
PDGF Signaling 72h 1.14 0.0253 KRAS,STAT3 2
Caveolar-mediated Endocytosis 
Signaling
72h 1.15 0.0235 ITGB2,ACTG2 2
Prolactin Signaling 72h 1.15 0.025 KRAS,STAT3 2
HER-2 Signaling in Breast 
Cancer
72h 1.15 0.025 ITGB2,KRAS 2
NF-κB Activation by Viruses 72h 1.17 0.0244 ITGB2,KRAS 2
CCR5 Signaling in 
Macrophages
72h 1.17 0.0213 CD247,CD3D 2
Chemokine Signaling 72h 1.18 0.0274 KRAS,LIMK2 2
FLT3 Signaling in 
Hematopoietic Progenitor Cells
72h 1.19 0.027 KRAS,STAT3 2
IL-3 Signaling 72h 1.2 0.027 KRAS,STAT3 2
T Helper Cell Differentiation 72h 1.22 0.0278 IFNGR2,STAT3 2
Macropinocytosis Signaling 72h 1.24 0.0263 ITGB2,KRAS 2
JAK/Stat Signaling 72h 1.25 0.0286 KRAS,STAT3 2
ERK5 Signaling 72h 1.3 0.0312 KRAS,MAP3K3 2
GM-CSF Signaling 72h 1.3 0.0299 KRAS,STAT3 2
Role of JAK1 and JAK3 in γc 
Cytokine Signaling
72h 1.31 0.0299 KRAS,STAT3 2
IL-15 Signaling 72h 1.32 0.0299 KRAS,STAT3 2
Thrombopoietin Signaling 72h 1.35 0.0317 KRAS,STAT3 2
ErbB2-ErbB3 Signaling 72h 1.39 0.0339 KRAS,STAT3 2
Role of CHK Proteins in Cell 
Cycle Checkpoint Control
72h 1.42 0.0357 PCNA,CDK1 2
CNTF Signaling 72h 1.45 0.0364 KRAS,STAT3 2
Hematopoiesis from Pluripotent 
Stem Cells
72h 1.45 0.0312 CD247,CD3D 2
MSP-RON Signaling Pathway 72h 1.53 0.0392 ITGB2,ACTG2 2
Oncostatin M Signaling 72h 1.79 0.0571 KRAS,STAT3 2
Role of JAK1, JAK2 and TYK2 
in Interferon Signaling
72h 2.08 0.0741 IFNGR2,STAT3 2
GADD45 Signaling 72h 2.28 0.0909 PCNA,CDK1 2
Mismatch Repair in Eukaryotes 72h 2.33 0.0833 PCNA,FEN1 2
Fatty Acid Metabolism 72h 0.21 0.00546 ACAT2 1
CXCR4 Signaling 72h 0.22 0.00595 KRAS 1
Tight Junction Signaling 72h 0.228 0.00613 ACTG2 1
Glioblastoma Multiforme 
Signaling
72h 0.228 0.00595 KRAS 1
Cellular Effects of Sildenafil 
(Viagra)
72h 0.241 0.00645 ACTG2 1
eNOS Signaling 72h 0.251 0.00662 HSPA8 1
Aryl Hydrocarbon Receptor 
Signaling
72h 0.253 0.00629 CTSD 1
Hepatic Fibrosis / Hepatic 
Stellate Cell Activation
72h 0.257 0.0068 IFNGR2 1
Cardiac β-adrenergic Signaling 72h 0.257 0.00649 AKAP9 1
Ovarian Cancer Signaling 72h 0.269 0.00704 KRAS 1
Insulin Receptor Signaling 72h 0.274 0.00735 KRAS 1
P2Y Purigenic Receptor 
Signaling Pathway
72h 0.276 0.00714 KRAS 1
p70S6K Signaling 72h 0.28 0.00752 KRAS 1
Estrogen Receptor Signaling 72h 0.285 0.00735 KRAS 1
Arginine and Proline 
Metabolism
72h 0.287 0.00565 RARS 1
PI3K/AKT Signaling 72h 0.294 0.00719 KRAS 1
14-3-3-mediated Signaling 72h 0.302 0.0082 KRAS 1
Atherosclerosis Signaling 72h 0.304 0.00763 ITGB2 1
Gα12/13 Signaling 72h 0.304 0.00787 KRAS 1
fMLP Signaling in Neutrophils 72h 0.315 0.00781 KRAS 1
PTEN Signaling 72h 0.318 0.00781 KRAS 1
Glycolysis/Gluconeogenesis 72h 0.323 0.00769 PGAM1 1
Fc Epsilon RI Signaling 72h 0.331 0.00901 KRAS 1
Neuropathic Pain Signaling In 
Dorsal Horn Neurons
72h 0.334 0.00893 GRIA1 1
Cholecystokinin/Gastrin-
mediated Signaling
72h 0.34 0.00943 KRAS 1
HIF1α Signaling 72h 0.346 0.00935 KRAS 1
Glioma Signaling 72h 0.359 0.00893 KRAS 1
Telomerase Signaling 72h 0.362 0.0098 KRAS 1
Fcγ Receptor-mediated 
Phagocytosis in Macrophages 
and Monocytes
72h 0.365 0.0098 ACTG2 1
G Beta Gamma Signaling 72h 0.365 0.00862 KRAS 1
α-Adrenergic Signaling 72h 0.369 0.00952 KRAS 1
Valine, Leucine and Isoleucine 
Degradation
72h 0.369 0.00935 ACAT2 1
Role of Pattern Recognition 
Receptors in Recognition of 
Bacteria and Viruses
72h 0.372 0.00943 EIF2S1 1
PPAR Signaling 72h 0.375 0.00943 KRAS 1
Starch and Sucrose Metabolism 72h 0.379 0.00602 UGDH 1
Neuregulin Signaling 72h 0.382 0.0098 KRAS 1
Chronic Myeloid Leukemia 
Signaling
72h 0.382 0.00962 KRAS 1
CDK5 Signaling 72h 0.39 0.0106 KRAS 1
Crosstalk between Dendritic 
Cells and Natural Killer Cells
72h 0.393 0.0105 ACTG2 1
Bladder Cancer Signaling 72h 0.401 0.011 KRAS 1
RANK Signaling in Osteoclasts 72h 0.401 0.0105 MAP3K3 1
FGF Signaling 72h 0.401 0.0111 STAT3 1
Melanocyte Development and 
Pigmentation Signaling
72h 0.405 0.0109 KRAS 1
Regulation of Actin-based 
Motility by Rho
72h 0.409 0.011 ACTG2 1
Prostate Cancer Signaling 72h 0.412 0.0103 KRAS 1
ErbB Signaling 72h 0.412 0.0115 KRAS 1
Butanoate Metabolism 72h 0.416 0.00781 ACAT2 1
Leptin Signaling in Obesity 72h 0.421 0.0114 STAT3 1
TGF-β Signaling 72h 0.421 0.0112 KRAS 1
Propanoate Metabolism 72h 0.421 0.00826 ACAT2 1
VEGF Family Ligand-Receptor 
Interactions
72h 0.425 0.0119 KRAS 1
Reelin Signaling in Neurons 72h 0.437 0.0122 ITGB2 1
Cyclins and Cell Cycle 
Regulation
72h 0.442 0.0114 CDK1 1
Aminoacyl-tRNA Biosynthesis 72h 0.455 0.0132 RARS 1
Cysteine Metabolism 72h 0.46 0.0111 Sult1d1 1
LPS-stimulated MAPK 
Signaling
72h 0.465 0.0122 KRAS 1
BMP signaling pathway 72h 0.465 0.0125 KRAS 1
IL-10 Signaling 72h 0.47 0.0128 STAT3 1
IL-17 Signaling 72h 0.47 0.0135 KRAS 1
Growth Hormone Signaling 72h 0.47 0.0133 STAT3 1
Renal Cell Carcinoma Signaling 72h 0.47 0.0135 KRAS 1
Non-Small Cell Lung Cancer 
Signaling
72h 0.475 0.0127 KRAS 1
GDNF Family Ligand-Receptor 
Interactions
72h 0.475 0.0137 KRAS 1
Erythropoietin Signaling 72h 0.48 0.0128 KRAS 1
IL-4 Signaling 72h 0.48 0.0137 KRAS 1
Neurotrophin/TRK Signaling 72h 0.48 0.0137 KRAS 1
Pentose and Glucuronate 
Interconversions
72h 0.49 0.00704 UGDH 1
Chondroitin Sulfate 
Biosynthesis
72h 0.495 0.0147 Sult1d1 1
Angiopoietin Signaling 72h 0.495 0.0135 KRAS 1
Antiproliferative Role of 
Somatostatin Receptor 2
72h 0.495 0.0141 KRAS 1
Role of MAPK Signaling in the 
Pathogenesis of Influenza
72h 0.495 0.0147 KRAS 1
Mitotic Roles of Polo-Like 
Kinase
72h 0.501 0.0145 CDK1 1
Retinoic acid Mediated 
Apoptosis Signaling
72h 0.501 0.0147 DAP3 1
N-Glycan Biosynthesis 72h 0.501 0.0123 MAN1B1 1
IL-17A Signaling in Airway Cells 72h 0.506 0.0139 STAT3 1
Glutamate Receptor Signaling 72h 0.512 0.0145 GRIA1 1
Estrogen-Dependent Breast 
Cancer Signaling
72h 0.512 0.0143 KRAS 1
CD40 Signaling 72h 0.517 0.0143 STAT3 1
Nitrogen Metabolism 72h 0.523 0.0084 37316 1
Biosynthesis of Steroids 72h 0.529 0.008 LSS 1
ErbB4 Signaling 72h 0.529 0.0152 KRAS 1
TREM1 Signaling 72h 0.535 0.0141 STAT3 1
Myc Mediated Apoptosis 
Signaling
72h 0.541 0.0164 KRAS 1
Glioma Invasiveness Signaling 72h 0.547 0.0167 KRAS 1
Keratan Sulfate Biosynthesis 72h 0.554 0.0175 Sult1d1 1
ATM Signaling 72h 0.554 0.0169 CDK1 1
Actin Nucleation by ARP-WASP 
Complex
72h 0.56 0.0152 KRAS 1
IL-2 Signaling 72h 0.567 0.0172 KRAS 1
Glycosaminoglycan 
Degradation
72h 0.574 0.0172 NAGLU 1
Endometrial Cancer Signaling 72h 0.574 0.0175 KRAS 1
Semaphorin Signaling in 
Neurons
72h 0.588 0.0192 LIMK2 1
nNOS Signaling in Neurons 72h 0.588 0.0192 CAPN2 1
Amyloid Processing 72h 0.588 0.0179 CAPN2 1
CD27 Signaling in Lymphocytes 72h 0.595 0.0175 MAP3K3 1
EGF Signaling 72h 0.602 0.0192 STAT3 1
Citrate Cycle 72h 0.602 0.0175 DLST 1
iNOS Signaling 72h 0.626 0.0189 IFNGR2 1
FcγRIIB Signaling in B 
Lymphocytes
72h 0.642 0.0169 KRAS 1
Melanoma Signaling 72h 0.651 0.0217 KRAS 1
Cell Cycle: G2/M DNA Damage 
Checkpoint Regulation
72h 0.651 0.0204 CDK1 1
Thyroid Cancer Signaling 72h 0.678 0.0238 KRAS 1
Role of PKR in Interferon 
Induction and Antiviral 
Response
72h 0.687 0.0217 EIF2S1 1
Mechanisms of Viral Exit from 
Host Cells
72h 0.687 0.0222 ACTG2 1
Transcriptional Regulatory 
Network in Embryonic Stem 
Cells
72h 0.687 0.025 STAT3 1
Sulfur Metabolism 72h 0.728 0.0172 Sult1d1 1
Nucleotide Excision Repair 
Pathway
72h 0.74 0.0286 XPA 1
IL-9 Signaling 72h 0.751 0.025 STAT3 1
Role of JAK2 in Hormone-like 
Cytokine Signaling
72h 0.751 0.0278 STAT3 1
Interferon Signaling 72h 0.751 0.0278 IFNGR2 1
B Cell Development 72h 0.775 0.0303 PTPRC 1
Sonic Hedgehog Signaling 72h 0.8 0.0303 CDK1 1
N-Glycan Degradation 72h 0.843 0.037 MAN1B1 1
Cell Cycle Control of 
Chromosomal Replication
72h 0.843 0.0323 MCM5 1
Role of JAK family kinases in IL-
6-type Cytokine Signaling
72h 0.874 0.037 STAT3 1
IL-22 Signaling 72h 0.89 0.04 STAT3 1
Estrogen-mediated S-phase 
Entry
72h 0.89 0.0357 CDK1 1
Polyamine Regulation in Colon 
Cancer
72h 0.907 0.0345 KRAS 1
Nucleotide Sugars Metabolism 72h 0.965 0.0154 UGDH 1
RAN Signaling 72h 0.986 0.0417 RAN 1
Endoplasmic Reticulum Stress 
Pathway
72h 1.01 0.0556 EIF2S1 1
Synthesis and Degradation of 
Ketone Bodies
72h 1.03 0.0526 ACAT2 1
